BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 14, Issue 27
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (11108)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.
Item 
Count 
PDF1378
HTML9462
Figures (1-1)150
Tables (1-1)118
 Sum=11108
Jul 21, 2008 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14(27): 4300-4308 [PMID: 18666317 DOI: 10.3748/wjg.14.4300]
URL: https://www.wjgnet.com/1948-5182/full/v14/i27/4300.htm
Number Citing Articles
1
Seulki Lee, Minjong Lee, Jong Bin Kim, Ara Jo, Eun Ju Cho, Su Jong Yu, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. Biochemical and Biophysical Research Communications 2016; 473(4): 1247 doi: 10.1016/j.bbrc.2016.04.049
2
Mirko Tarocchi, Simone Polvani, Giada Marroncini, Andrea Galli. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World Journal of Gastroenterology 2014; 20(33): 11630-11640 doi: 10.3748/wjg.v20.i33.11630
3
Sergei N Shchelkunov, Galina A Shchelkunova. Plant-based vaccines against human hepatitis B virus. Expert Review of Vaccines 2010; 9(8): 947 doi: 10.1586/erv.10.67
4
Xin Xu, Yuquan Tao, Yongjie Niu, Zhixian Wang, Congcong Zhang, Yongchun Yu, Lifang Ma. miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma. Aging 2019; 11(18): 7639 doi: 10.18632/aging.102276
5
EMILIA HADZIYANNIS, KONSTANTINOS SIALEVRIS, ANASTASIA GEORGIOU, JOHN KOSKINAS. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels. Oncology Reports 2013; 29(2): 835 doi: 10.3892/or.2012.2147
6
C. Rory Goodwin, Vijay Yanamadala, Alejandro Ruiz-Valls, Nancy Abu-Bonsrah, Ganesh Shankar, Eric W. Sankey, Christine Boone, Michelle J. Clarke, Mark Bilsky, Ilya Laufer, Charles Fisher, John H. Shin, Daniel M. Sciubba. A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine. World Neurosurgery 2016; 91: 510 doi: 10.1016/j.wneu.2016.04.026
7
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
8
Rebecca Jeyaraj, Deirdre Kelly. Rare Inherited Cholestatic Disorders and Molecular Links to Hepatocarcinogenesis. Cells 2022; 11(16): 2570 doi: 10.3390/cells11162570
9
Francesco Paolo Russo, Kryssia Rodríguez-Castro, Laura Scribano, Giorgia Gottardo, Veronica Vanin, Fabio Farinati. Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease. World Journal of Hepatology 2015; 7(8): 1097-1104 doi: 10.4254/wjh.v7.i8.1097
10
Sk Ramiz Islam, Soumen Kanti Manna. Identification of glucose-independent and reversible metabolic pathways associated with anti-proliferative effect of metformin in liver cancer cells. Metabolomics 2024; 20(2) doi: 10.1007/s11306-024-02096-0
11
Huarong Chen, Jun Yu. Liver Diseases. 2020; : 85 doi: 10.1007/978-3-030-24432-3_8
12
Joji Nakayama, Zhiyuan Gong. Transgenic zebrafish for modeling hepatocellular carcinoma. MedComm 2020; 1(2): 140 doi: 10.1002/mco2.29
13
Shuang Liu, Jie An, Jianhong Lin, Yanli Liu, Lidao Bao, Wen Zhang, Jian-Jun Zhao, Zhengdong Zhang. Single Nucleotide Polymorphisms of MicroRNA Processing Machinery Genes and Outcome of Hepatocellular Carcinoma. PLoS ONE 2014; 9(3): e92791 doi: 10.1371/journal.pone.0092791
14
Aducio L. Thiesen. Liver Cancer. 2021; : 39 doi: 10.36255/exonpublications.livercancer.2021.ch2
15
Ali Habib, Kush Desai, Ryan Hickey, Bartley Thornburg, Robert Lewandowski, Riad Salem. Transarterial approaches to primary and secondary hepatic malignancies. Nature Reviews Clinical Oncology 2015; 12(8): 481 doi: 10.1038/nrclinonc.2015.78
16
Peng Yuan, Peng Chen, Yeben Qian. Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/5234969
17
Kheng Leong Ooi, Tengku Sifzizul Tengku Muhammad, Lee Yein Lam, Shaida Fariza Sulaiman. Cytotoxic and Apoptotic Effects of Ethyl Acetate Extract of Elephantopus mollis Kunth. in Human Liver Carcinoma HepG2 Cells Through Caspase-3 Activation. Integrative Cancer Therapies 2014; 13(3): NP1 doi: 10.1177/1534735411433203
18
Ola M Eid, Nivine A Helmy, Islam H Fadel, Waffa M Ezzat, Refaat R Kamel, Maha M Eid. Hepatitis C virus and schistosomiasis as a causative factor for hTERT amplification in hepatocellular carcinoma. Gene Reports 2016; 5: 108 doi: 10.1016/j.genrep.2016.09.013
19
Kyle J. Thompson, Kwan N. Lau, Sarah Johnson, John B. Martinie, David A. Iannitti, Iain H. McKillop, David Sindram. Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling. HPB 2011; 13(4): 225 doi: 10.1111/j.1477-2574.2010.00259.x
20
Xiaotong Su, Jutong Su, Hua He, Yong Zhan, Haichao Liu. Hsa_circ_0070269 inhibits hepatocellular carcinoma progression through modulating miR-182/NPTX1 axis. Biomedicine & Pharmacotherapy 2019; 120: 109497 doi: 10.1016/j.biopha.2019.109497
21
Duguang Li, Junhai Pan, Yiyin Zhang, Yirun Li, Shengxi Jin, Cheng Zhong, Peng Chen, Jingjing Ma, Wendi Hu, Xiaoxiao Fan, Hui Lin. C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11. Cancers 2022; 14(14): 3410 doi: 10.3390/cancers14143410
22
Qing-Lian Chen, Qian Yan, Kun-Liang Feng, Chun-Feng Xie, Chong-Kai Fang, Ji-Nan Wang, Li-Hua Liu, Ya Li, Chong Zhong. Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma. International Journal of General Medicine 2021; : 805 doi: 10.2147/IJGM.S294505
23
Xiang Lyu, Kui Liu, Yongdi Chen, Zhifang Wang, Jun Yao, Gaofeng Cai, Zhenggang Jiang, Zhengting Wang, Jianmin Jiang, Hua Gu. Analysis of Risk Factors Associated with the Development of Hepatocellular Carcinoma in Chronic HBV-Infected Chinese: A Meta-Analysis. International Journal of Environmental Research and Public Health 2016; 13(6): 604 doi: 10.3390/ijerph13060604
24
A V Tkachev, G N Tarasova, V S Groshilin, D A Vasilchenkov, T I Ushakova, D V Blinov. Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study. Terapevticheskii arkhiv 2016; 88(8): 59 doi: 10.17116/terarkh201688859-66
25
K. Tajima, A. Nakamura, J. Shirakawa, Y. Togashi, K. Orime, K. Sato, H. Inoue, M. Kaji, E. Sakamoto, Y. Ito, K. Aoki, Y. Nagashima, T. Atsumi, Y. Terauchi. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. American Journal of Physiology-Endocrinology and Metabolism 2013; 305(8): E987 doi: 10.1152/ajpendo.00133.2013
26
Yang Liu, Kazuyuki Sogawa, Masahiko Sunaga, Hiroshi Umemura, Mamoru Satoh, Takahiro Kazami, Masaharu Yoshikawa, Takeshi Tomonaga, Osamu Yokosuka, Fumio Nomura. Increased Concentrations of Apo A-I and Apo A-II Fragments in the Serum of Patients With Hepatocellular Carcinoma by Magnetic Beads–Assisted MALDI-TOF Mass Spectrometry. American Journal of Clinical Pathology 2014; 141(1): 52 doi: 10.1309/AJCPBLFBNAP6N2UN
27
Sarah Hassan, Soheir S Mansy, Sahar A Tabak, Ahmed S AbdelFattah, Ahmed M Abdel-Aziz, Olfat Hamam, Mohammed I Seleem, Amr Abdelaal. Immunohistochemical and electron microscopic morphometric image analysis of hepatocellular carcinoma in association of HCV infection. Ultrastructural Pathology 2018; 42(2): 97 doi: 10.1080/01913123.2017.1422065
28
Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman. Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysis. Transplantation Reviews 2023; 37(3): 100763 doi: 10.1016/j.trre.2023.100763
29
K. Sartorius, B. Sartorius, C. Aldous, P.S. Govender, T.E. Madiba. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiology 2015; 39(3): 284 doi: 10.1016/j.canep.2015.04.006
30
Wasim Jafri, Muhammad Kamran. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian Journal of Hepato-Gastroenterology 2019; 9(1): 27 doi: 10.5005/jp-journals-10018-1292
31
E H Yun, M K Lim, J-K Oh, J H Park, A Shin, J Sung, E-C Park. Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea. British Journal of Cancer 2010; 103(5): 741 doi: 10.1038/sj.bjc.6605803
32
Javier Ampuero, Manuel Romero-Gomez. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin. World Journal of Hepatology 2015; 7(8): 1105-1111 doi: 10.4254/wjh.v7.i8.1105
33
Mohamed A. Elwakil, Ekbal M. Abo-Hashem, Yasser M. Shabana, Mohamed A. El-Metwall, Ghada El-Kannish, Ali M. El-Adl, Rokiah Anwar, Eman Fawzy, Narmin Saied, Mustafa M. El-Zayat. Hepatocellular Carcinoma in Populations Consuming Heavy Metals Contaminated Plants in North Delta, Egypt. Research Journal of Environmental Toxicology 2017; 11(2): 55 doi: 10.3923/rjet.2017.55.61
34
Yoshitaka Takuma, Kazuhiro Nouso, Yasuhiro Makino, Tomoyuki Gotoh, Nobuyuki Toshikuni, Youichi Morimoto, Hiroyuki Shimomura, Hiroshi Yamamoto. Outcomes after curative treatment for cryptogenic cirrhosis‐associated hepatocellular carcinoma satisfying the Milan criteria. Journal of Gastroenterology and Hepatology 2011; 26(9): 1417 doi: 10.1111/j.1440-1746.2011.06775.x
35
Ana Paula Pagano, Juliana Maria Faccioli Sicchieri, Clara Romanholi Passos, Camila Sanches Manca, Isabela Laurencio Schiavoni, Andreza Correa Teixeira, Ana de Lourdes Candolo Martinelli, Paula Garcia Chiarello. Hand grip strength and adductor pollicis muscle thickness in patients on palliative care for hepatocellular carcinoma. Clinical Nutrition Experimental 2018; 22: 30 doi: 10.1016/j.yclnex.2018.06.003
36
Yoshitaka Takuma, Hiroyuki Takabatake, Youichi Morimoto, Nobuyuki Toshikuni, Takahisa Kayahara, Yasuhiro Makino, Hiroshi Yamamoto. Comparison of Combined Transcatheter Arterial Chemoembolization and Radiofrequency Ablation with Surgical Resection by Using Propensity Score Matching in Patients with Hepatocellular Carcinoma within Milan Criteria. Radiology 2013; 269(3): 927 doi: 10.1148/radiol.13130387
37
Neneng Ratnasari, Puji Lestari, Dede Renovaldi, Juwita Raditya Ningsih, Nanda Qoriansas, Tirta Wardana, Suharno Hakim, Nur Signa Aini Gumilas, Fahmi Indrarti, Catharina Triwikatmani, Putut Bayupurnama, Didik Setyo Heriyanto, Indwiani Astuti, Sofia Mubarika Harjana, Ratna B. Ray. Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients. PLOS ONE 2022; 17(2): e0263298 doi: 10.1371/journal.pone.0263298
38
Yun Hak Kim, Dae Cheon Jeong, Kyoungjune Pak, Myoung-Eun Han, Ji-Young Kim, Liu Liangwen, Hyun Jin Kim, Tae Woo Kim, Tae Hwa Kim, Dong Woo Hyun, Sae-Ock Oh. SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma. Oncotarget 2017; 8(40): 68381 doi: 10.18632/oncotarget.20266
39
Bipul Gnyawali, Antoinette Pusateri, Ashley Nickerson, Sajid Jalil, Khalid Mumtaz. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(29): 3793-3802 doi: 10.3748/wjg.v28.i29.3793
40
Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, Ailica Wan Xin Lee, Desiree Shu Hui Tay, Jack Jie En Tan, Sze Huey Tan, Su Pin Choo, David Wai‐Meng Tai, Joycelyn Jie Xin Lee. Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?. Asia-Pacific Journal of Clinical Oncology 2023; 19(3): 312 doi: 10.1111/ajco.13837
41
Linyou Cheng, Ming Liu, Cuicui Wang, Haizhou Liu, Yuyan Zhang, Xiukun Lin. CI431, an Aqueous Compound fromCiona intestinalis L., Induces Apoptosis through a Mitochondria-Mediated Pathway in Human Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2011; 2011: 1 doi: 10.1155/2011/292873
42
Han-Syuan Lin, Yi-Luen Huang, Yi-Rui Stefanie Wang, Eugene Hsiao, Tsu-An Hsu, Hui-Yi Shiao, Weir-Torn Jiaang, Bonifasius Putera Sampurna, Kuan-Hao Lin, Ming-Shun Wu, Gi-Ming Lai, Chiou-Hwa Yuh. Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform. Cancers 2019; 11(6): 739 doi: 10.3390/cancers11060739
43
Young-Joo Jin, Seyoun Byun, Seonggyun Han, John Chamberlin, Dongwook Kim, Min Jung Kim, Younghee Lee. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors. BMC Medical Genomics 2019; 12(S8) doi: 10.1186/s12920-019-0635-z
44
Ruixing Zhang, Fengbin Zhang, Cuiju Wang, Shunxiang Wang, Yih-Horng Shiao, Zhanjun Guo. Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. Journal of Experimental & Clinical Cancer Research 2010; 29(1) doi: 10.1186/1756-9966-29-130
45
Luca Quagliata, Matthias S. Matter, Salvatore Piscuoglio, Leila Arabi, Christian Ruiz, Alfredo Procino, Michal Kovac, Francesca Moretti, Zuzanna Makowska, Tujana Boldanova, Jesper B. Andersen, Monika Hämmerle, Luigi Tornillo, Markus H. Heim, Sven Diederichs, Clemente Cillo, Luigi M. Terracciano. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology 2014; 59(3): 911 doi: 10.1002/hep.26740
46
Anokh Pahwa, Katrina Beckett, Stephanie Channual, Nelly Tan, David S. Lu, Steven S. Raman. Efficacy of the American Association for the Study of Liver Disease and Barcelona criteria for the diagnosis of hepatocellular carcinoma. Abdominal Imaging 2014; 39(4): 753 doi: 10.1007/s00261-014-0118-9
47
Hitoshi Maruyama, Arun J. Sanyal. Clinical Dilemmas in Primary Liver Cancer. 2011; : 29 doi: 10.1002/9781119962205.ch5
48
Bita Geramizadeh, Nasibe Seirfar. Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver. Hepatitis Monthly 2015; 15(6) doi: 10.5812/hepatmon30336v2
49
Aleksandra Barac. Clinically Relevant Mycoses. 2019; : 213 doi: 10.1007/978-3-319-92300-0_14
50
G A Siregar, R H Siregar. Gamma-glutamyltranspeptidase to platelet ratio and albumin to gamma-glutamyltranspeptidase between degrees of the Barcelona clinic liver cancer on hepatocellular carcinoma patients in Haji Adam Malik general hospital Medan during 2015-2016. IOP Conference Series: Earth and Environmental Science 2018; 125: 012135 doi: 10.1088/1755-1315/125/1/012135
51
Ágnes Holczbauer, Kirk J. Wangensteen, Soona Shin. Cellular origins of regenerating liver and hepatocellular carcinoma. JHEP Reports 2022; 4(4): 100416 doi: 10.1016/j.jhepr.2021.100416
52
Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, W. Ray Kim, Leland J. Yee, Craig Brooks-Rooney, Tristan Curteis, Harriet Cant, Chien-Hung Chen, Chi-Yi Chen, Yi-Hsiang Huang, Young-Joo Jin, Dae Won Jun, Jin-Wook Kim, Neung Hwa Park, Cheng-Yuan Peng, Hyun Phil Shin, Jung Woo Shin, Yao-Hsu Yang, Young-Suk Lim. Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis. Journal of Hepatology 2023; 78(3): 534 doi: 10.1016/j.jhep.2022.12.007
53
Alastair L. Young, Robert Adair, Rajendra K. Prasad, Giles J. Toogood, Peter A.J. Lodge. Hepatocellular Carcinoma Within a Noncirrhotic, Nonfibrotic, Seronegative Liver: Surgical Approaches and Outcomes. Journal of the American College of Surgeons 2012; 214(2): 174 doi: 10.1016/j.jamcollsurg.2011.10.005
54
Chen-Chun Lin, Chien-Fu Hung, Wei-Ting Chen, Shi-Ming Lin. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment. Liver Cancer 2015; 4(4): 228 doi: 10.1159/000367737
55
Pedro L. Prieto-Hontoria, Patricia Pérez-Matute, Marta Fernández-Galilea, Matilde Bustos, J. Alfredo Martínez, María J. Moreno-Aliaga. Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2011; 1807(6): 664 doi: 10.1016/j.bbabio.2010.11.004
56
Anh Tuan Nguyen, Alexander Emelyanov, Chor Hui Vivien Koh, Jan M. Spitsbergen, Serguei Parinov, Zhiyuan Gong. An inducible kras V12 transgenic zebrafish model for liver tumorigenesis and chemical drug screening. Disease Models & Mechanisms 2012; 5(1): 63 doi: 10.1242/dmm.008367
57
Hung-Chih Yang, Shiou-Hwei Yeh, Pei-Jer Chen, Ding-Shinn Chen. Viruses and Human Cancer. 2014; : 113 doi: 10.1007/978-1-4939-0870-7_6
58
Omer Senarslan, Umut Hasan Kantarci, Mehmet Eyuboglu, Dilsad Amanvermez Senarslan. Is it possible? Invasion of the heart with hepatocellular carcinoma in a short time. International Journal of the Cardiovascular Academy 2016; 2(3): 124 doi: 10.1016/j.ijcac.2016.06.002
59
Brandon M. Meyers, Jennifer J. Knox, David M. Liu, Deanna McLeod, Ravi Ramjeesingh, Vincent C. Tam, Howard J. Lim. The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review. Cancer Treatment Reviews 2023; 118: 102584 doi: 10.1016/j.ctrv.2023.102584
60
Gabriel Wcislo, Katarzyna Szarlej-Wcislo. Health of HIV Infected People. 2015; : 59 doi: 10.1016/B978-0-12-800769-3.00004-4
61
Marie-Pierre Lambert, Pierre-Benoit Ancey, Davide Degli Esposti, Marie-Pierre Cros, Athena Sklias, Jean-Yves Scoazec, David Durantel, Hector Hernandez-Vargas, Zdenko Herceg. Aberrant DNA methylation of imprinted loci in hepatocellular carcinoma and after in vitro exposure to common risk factors. Clinical Epigenetics 2015; 7(1) doi: 10.1186/s13148-015-0053-9
62
D. SAUNDERS, D. SEIDEL, M. ALLISON, G. LYRATZOPOULOS. Systematic review: the association between obesity and hepatocellular carcinoma – epidemiological evidence. Alimentary Pharmacology & Therapeutics 2010; 31(10): 1051 doi: 10.1111/j.1365-2036.2010.04271.x
63
Michael C. Kew. Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Annals of Hepatology 2013; 12(2): 173 doi: 10.1016/S1665-2681(19)31354-7
64
Alessia Marino, Francesca Ori, Giovanni Pacioni, Marco Leonardi, Mirco Iotti. Characterization of culturable truffle-inhabiting fungi isolated from Tuber melanosporum, T. aestivum and T. borchii ascomata. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology 2023; 157(5): 978 doi: 10.1080/11263504.2023.2234904
65
Nada Assi, Duncan C. Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M. Sandanger, Amaia Molinuevo, Hendriek C. Boshuizen, Anneli Sundkvist, Tilman Kühn, Ruth C. Travis, Kim Overvad, Elio Riboli, Marc J. Gunter, Augustin Scalbert, Mazda Jenab, Pietro Ferrari, Vivian Viallon. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case–Control Study in EPIC. Cancer Epidemiology, Biomarkers & Prevention 2018; 27(5): 531 doi: 10.1158/1055-9965.EPI-17-0649
66
Thomas von Hahn, Sandra Ciesek, Gerd Wegener, Ruben R. Plentz, Tobias J. Weismüller, Heiner Wedemeyer, Michael P. Manns, Tim F. Greten, Nisar P. Malek. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scandinavian Journal of Gastroenterology 2011; 46(9): 1092 doi: 10.3109/00365521.2011.589472
67
Tung-Ching Ho, Er-Yea Wang, Kun-Huei Yeh, Yung-Ming Jeng, Jau-Hau Horng, Li-Ling Wu, Yi-Tzu Chen, Hsuan-Cheng Huang, Chia-Lang Hsu, Pei-Jer Chen, Shiou-Hwei Yeh, Ding-Shinn Chen. Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver. Proceedings of the National Academy of Sciences 2020; 117(12): 6717 doi: 10.1073/pnas.1918028117
68
Chunxiao Zhou, Qiang Yu, Lei Chen, Jian Wang, Shudan Zheng, Jinkun Zhang. A miR-1231 binding site polymorphism in the 3′UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility. Gene 2012; 507(1): 95 doi: 10.1016/j.gene.2012.06.073
69
R. CABRERA, D. R. NELSON. Review article: the management of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2010; 31(4): 461 doi: 10.1111/j.1365-2036.2009.04200.x
70
Fanghua Qi, Anyuan Li, Lin Zhao, Huanli Xu, Yoshinori Inagaki, Dongliang Wang, Xiaoyan Cui, Bo Gao, Norihiro Kokudo, Munehiro Nakata, Wei Tang. Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. Journal of Ethnopharmacology 2010; 128(3): 654 doi: 10.1016/j.jep.2010.02.022
71
Monika Moser, Iuliana‐Pompilia Radu, Jean‐François Dufour. Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib. JGH Open 2021; 5(8): 864 doi: 10.1002/jgh3.12533
72
Fengju OuYang, Guibin Wang, Wei Guo, Yuanyuan Zhang, Wenhua Xiang, Min Zhao. AKT signalling and mitochondrial pathways are involved in mushroom polysaccharide-induced apoptosis and G1 or S phase arrest in human hepatoma cells. Food Chemistry 2013; 138(4): 2130 doi: 10.1016/j.foodchem.2012.10.047
73
Prabu Thangavel, Ragunath Muthu, Manju Vaiyapuri. Antioxidant potential of naringin – a dietary flavonoid – in N-Nitrosodiethylamine induced rat liver carcinogenesis. Biomedicine & Preventive Nutrition 2012; 2(3): 193 doi: 10.1016/j.bionut.2012.03.006
74
Chuan-Ping Feng, Hai-Ming Tang, Song Huang, Shao-Zhen Hou, Jian Liang, Wei Huang, Xiao-Ping Lai. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms. Journal of Ethnopharmacology 2016; 188: 70 doi: 10.1016/j.jep.2016.04.042
75
Min-Ae Song, Maarit Tiirikainen, Sandi Kwee, Gordon Okimoto, Herbert Yu, Linda L. Wong, Alejandro H. Corvalan. Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma. PLoS ONE 2013; 8(2): e55761 doi: 10.1371/journal.pone.0055761
76
Arig Aly Seif, Heba Hassan Aly, Doaa Mostafa Elzoghby, Ashraf Mohammed Elbreedy, Mohamed Lotfy. Aberrant p16 methylation as an early diagnostic marker in blood of hepatocellular carcinoma patients. Egyptian Journal of Medical Human Genetics 2019; 20(1) doi: 10.1186/s43042-019-0027-0
77
Ashish Goyal, John M. Murray, Yury E. Khudyakov. The Impact of Vaccination and Antiviral Therapy on Hepatitis B and Hepatitis D Epidemiology. PLoS ONE 2014; 9(10): e110143 doi: 10.1371/journal.pone.0110143
78
Omar A. Saldarriaga, Bradley Dye, Judy Pham, Timothy G. Wanninger, Daniel Millian, Michael Kueht, Benjamin Freiberg, Netanya Utay, Heather L. Stevenson. Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93881-7
79
Marthandam Asokan Shibu, Yi‐Ju Chen, Hong‐Siang Yang, Yen‐Hua He, Yun‐Hsin Lo, Wan‐Teng Lin. Principle active metabolites of Pinus morrisonicolaHayata synergistically inhibit cell proliferation and autophagy to elevate apoptosis in hepatocellular carcinoma cells. Environmental Toxicology 2023; 38(12): 3018 doi: 10.1002/tox.23935
80
The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019; 8(12): 1504 doi: 10.3390/cells8121504
81
Noriyuki Kitagawa, Hidenori Ojima, Takuya Shirakihara, Hiroko Shimizu, Akiko Kokubu, Tomoko Urushidate, Yasushi Totoki, Tomoo Kosuge, Shinichi Miyagawa, Tatsuhiro Shibata. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Science 2013; 104(5): 543 doi: 10.1111/cas.12126
82
Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu. The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.863352
83
Xin Deng, Xiao fang Zhao, Xing qiu Liang, Ran Chen, Yi feng Pan, Jian Liang. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 90: 100 doi: 10.1016/j.biopha.2017.03.031
84
Jing Gao, Li Xie, Wan-Shui Yang, Wei Zhang, Shan Gao, Jing Wang, Yong-Bing Xiang. Risk Factors of Hepatocellular Carcinoma - Current Status and Perspectives. Asian Pacific Journal of Cancer Prevention 2012; 13(3): 743 doi: 10.7314/APJCP.2012.13.3.743
85
Tanecia Mitchell, Balu Chacko, Scott W. Ballinger, Shannon M. Bailey, Jianhua Zhang, Victor Darley-Usmar. Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics. Biochemical Society Transactions 2013; 41(1): 127 doi: 10.1042/BST20120231
86
Nasim Habibi, Mohsen Nassiri-Toosi, Heidar Sharafi, Seyed Moayed Alavian, Masoomeh Shams-Ghahfarokhi, Mehdi Razzaghi-Abyaneh. Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C. Toxin Reviews 2019; 38(3): 234 doi: 10.1080/15569543.2018.1446027
87
Lu Shun Zhang, Fang Yuan, Xuan Guan, Juan Li, Xin Lian Liu, Jing Sun, Bo Liu, Wei Ma, Feng Mei Deng. Association of Genetic Polymorphisms in HSD17B1, HSD17B2 and SHBG Genes with Hepatocellular Carcinoma Risk. Pathology & Oncology Research 2014; 20(3): 661 doi: 10.1007/s12253-014-9746-1
88
Yuanshun Zhao, Yonghong Zhang, Dongdong Lin, Kang Li, Chengzeng Yin, Xiuhong Liu, Boxun Jin, Libo Sun, Jinhua Liu, Aiying Zhang, Ning Li. Protein microarray with horseradish peroxidase chemiluminescence for quantification of serum α-fetoprotein. Journal of International Medical Research 2015; 43(5): 639 doi: 10.1177/0300060515583075
89
Rou Li, Danni Li, Guorong Jia, Xiao Li, Gaofeng Sun, Changjing Zuo. Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.551622
90
Iván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, David Medina-Preciado, Juan Armendáriz-Borunda. Adenoviral gene therapy in hepatocellular carcinoma: a review. Hepatology International 2013; 7(1): 48 doi: 10.1007/s12072-012-9367-2
91
Chun-Man Lee, Benedetto Natalini. A Review on the Antimutagenic and Anticancer Effects of Cysteamine. Advances in Pharmacological and Pharmaceutical Sciences 2023; 2023: 1 doi: 10.1155/2023/2419444
92
Jin Lee, Kye‐Taek Lim. Phytoglycoprotein (38 kDa) induces cell cycle (G0/G1) arrest and apoptosis in HepG2 cells. Journal of Cellular Biochemistry 2011; 112(11): 3129 doi: 10.1002/jcb.23239
93
Arnolfo Petruzziello. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. The Open Virology Journal 2018; 12(1): 26 doi: 10.2174/1874357901812010026
94
Christopher Koh, T. Jake Liang. Settling the “score” with liver cancer. Journal of Hepatology 2009; 50(1): 7 doi: 10.1016/j.jhep.2008.10.008
95
Kimia Falamarzi, Mahdi Malekpour, Mobin Fallah Tafti, Negar Azarpira, Mehrdad Behboodi, Mohammad Zarei. The role of FGF21 and its analogs on liver associated diseases. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.967375
96
Daria Apostolo, Luciana L. Ferreira, Federica Vincenzi, Nicole Vercellino, Rosalba Minisini, Federico Latini, Barbara Ferrari, Michela E. Burlone, Mario Pirisi, Mattia Bellan. From MASH to HCC: the role of Gas6/TAM receptors. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1332818
97
Marius Farcas, Andrei-Alexandru Gavrea, Diana Gulei, Calin Ionescu, Alexandru Irimie, Cristina S. Catana, Ioana Berindan-Neagoe. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma. Frontiers in Nutrition 2019; 6 doi: 10.3389/fnut.2019.00148
98
Yashasavi Sachar, Mayur Brahmania, Renumathy Dhanasekaran, Stephen E. Congly. Screening for Hepatocellular Carcinoma in Patients with Hepatitis B. Viruses 2021; 13(7): 1318 doi: 10.3390/v13071318
99
Claire E. Thomas, Hung N. Luu, Renwei Wang, Guoxiang Xie, Jennifer Adams-Haduch, Aizhen Jin, Woon-Puay Koh, Wei Jia, Jaideep Behari, Jian-Min Yuan. Association between Pre-Diagnostic Serum Bile Acids and Hepatocellular Carcinoma: The Singapore Chinese Health Study. Cancers 2021; 13(11): 2648 doi: 10.3390/cancers13112648
100
Lee Jin Lim, Samuel Y.S. Wong, Feiyang Huang, Sheng Lim, Samuel S. Chong, London Lucien Ooi, Oi Lian Kon, Caroline G. Lee. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Research 2019; 79(20): 5131 doi: 10.1158/0008-5472.CAN-19-0255
101
Deepika Divya Kadiri, Sujatha Peela, Debayan Ganguli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 51 doi: 10.1016/B978-0-323-98806-3.00002-7
102
Catherine Yujia Gu, Terence Kin Wah Lee. Preclinical mouse models of hepatocellular carcinoma: An overview and update. Experimental Cell Research 2022; 412(2): 113042 doi: 10.1016/j.yexcr.2022.113042
103
Patrick Ying-Kit Yue, Yi-Yi Wong, Kay Yuen-Ki Wong, Yeuk-Ki Tsoi, Kelvin Sze-Yin Leung. Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea. Chinese Medicine 2013; 8(1): 21 doi: 10.1186/1749-8546-8-21
104
Somsak Likhitrattanapisal, Jaitip Tipanee, Tavan Janvilisri. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma. Tumor Biology 2016; 37(9): 12755 doi: 10.1007/s13277-016-5186-8
105
Yefan Zhu, Liang Zhao, Keqing Shi, Zitao Huang, Bicheng Chen. TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling. Experimental Cell Research 2018; 367(2): 274 doi: 10.1016/j.yexcr.2018.04.006
106
Jin Mi Chun, Kyoung Jin Nho, A. Yeong Lee, Byeong Cheol Moon, Jun Yeon Park, Ho Kyoung Kim. A methanol fraction from Chaenomeles sinensis inhibits hepatocellular carcinoma growth in vitro and in vivo. Journal of the Korean Society for Applied Biological Chemistry 2012; 55(3): 335 doi: 10.1007/s13765-012-1043-7
107
Fei Chen, Kevin Beezhold, Vince Castranova. JNK1, a potential therapeutic target for hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2009; 1796(2): 242 doi: 10.1016/j.bbcan.2009.06.005
108
Maha Alhelf, Rasha M. S. Shoaib, Afaf Elsaid, Nermeen Bastawy, Nanis S. Elbeltagy, Eman T. Salem, Sherif Refaat, Eman H. Abuelnadar. Prognostic significance of the genetic variant of lymphotoxin alpha (p.Thr60Asn) in egyptian patients with advanced hepatocellular carcinoma. Molecular Biology Reports 2023; 50(5): 4317 doi: 10.1007/s11033-023-08281-z
109
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International 2023; 43(10): 2062 doi: 10.1111/liv.15685
110
Jian-zhong Di, Xiao-dong Han, Wen-ye Gu, Yu Wang, Qi Zheng, Pin Zhang, Hui-min Wu, Zhong-zheng Zhu. Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. Journal of Zhejiang University SCIENCE B 2011; 12(10): 805 doi: 10.1631/jzus.B1000422
111
Yu-Chiau Shyu, Tung-Liang Lee, Mu-Jie Lu, Jim-Ray Chen, Rong-Nan Chien, Huang-Yang Chen, Ji-Fan Lin, Ann-Ping Tsou, Yu-Hsien Chen, Chia-Wen Hsieh, Ting-Shuo Huang. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0956-z
112
B. J. VENNERVALD, K. POLMAN. Helminths and malignancy. Parasite Immunology 2009; 31(11): 686 doi: 10.1111/j.1365-3024.2009.01163.x
113
Jingwang Bi, Chen Zhong, Kainan Li, Huili Chu, Baocheng Wang. Association Study of Single Nucleotide Polymorphisms inXRCC1Gene with Risk of Hepatocellular Carcinoma in Chinese Han Population. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/138785
114
Zeyu Zhang, Yufan Zhou, Jiajin Yang, Kuan Hu, Yun Huang. The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5735-9
115
Dawn Qingqing Chong, Iain Beehuat Tan, Su-Pin Choo, Han Chong Toh. The evolving landscape of therapeutic drug development for hepatocellular carcinoma. Contemporary Clinical Trials 2013; 36(2): 605 doi: 10.1016/j.cct.2013.03.013
116
Magdalena Stepien, David J Hughes, Sandra Hybsier, Christina Bamia, Anne Tjønneland, Kim Overvad, Aurélie Affret, Mathilde His, Marie-Christine Boutron-Ruault, Verena Katzke, Tilman Kühn, Krasimira Aleksandrova, Antonia Trichopoulou, Pagona Lagiou, Phlippos Orfanos, Domenico Palli, Sabina Sieri, Rosario Tumino, Fulvio Ricceri, Salvatore Panico, H B(as) Bueno-de-Mesquita, Petra H Peeters, Elisabete Weiderpass, Cristina Lasheras, Catalina Bonet Bonet, Elena Molina-Portillo, Miren Dorronsoro, José María Huerta, Aurelio Barricarte, Bodil Ohlsson, Klas Sjöberg, Mårten Werner, Dmitry Shungin, Nick Wareham, Kay-Tee Khaw, Ruth C Travis, Heinz Freisling, Amanda J Cross, Lutz Schomburg, Mazda Jenab. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans. British Journal of Cancer 2017; 116(5): 688 doi: 10.1038/bjc.2017.1
117
Dorra Trad, Norsaf Bibani, Meriam Sabbah, Hela Elloumi, Dalila Gargouri, Asma Ouakaa, Jamel Kharrat. Known, new and emerging risk factors of hepatocellular carcinoma (review). La Presse Médicale 2017; 46(11): 1000 doi: 10.1016/j.lpm.2017.09.025
118
Chien-Hsin Chang, Tur-Fu Huang, Kung-Tin Lin, Chun-Chieh Hsu, Wei-Luen Chang, Shih-Wei Wang, Feng-Nien Ko, Hui-Chin Peng, Ching-Hu Chung. 4-Acetylantroquinonol B Suppresses Tumor Growth and Metastasis of Hepatoma Cells via Blockade of Translation-Dependent Signaling Pathway and VEGF Production. Journal of Agricultural and Food Chemistry 2015; 63(1): 208 doi: 10.1021/jf504434v
119
Jie Liu, Guo-Zheng Yu, Xiao-Ke Cheng, Xiao-Dong Li, Xian-Tao Zeng, Xue-Qun Ren. LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition. Oncotarget 2017; 8(31): 50896 doi: 10.18632/oncotarget.15143
120
Akanksha Sharma, Ananya Shukla, Kriti Attri, Megha Kumar, Puneet Kumar, Ashish Suttee, Gurpal Singh, Ravi Pratap Barnwal, Neha Singla. Global trends in pesticides: A looming threat and viable alternatives. Ecotoxicology and Environmental Safety 2020; 201: 110812 doi: 10.1016/j.ecoenv.2020.110812
121
Chibo Liu, Haibao Wang, Chunqin Pan, Jianmin Shen, Yong Liang. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls. Tumor Biology 2012; 33(4): 979 doi: 10.1007/s13277-012-0326-2
122
Pathology of Liver Diseases. 2017; : 289 doi: 10.1002/9781118894903.ch14
123
Michele T. Yip-Schneider, Patrick J. Klein, Sabrina C. Wentz, Amer Zeni, Alex Menze, C. Max Schmidt. Resistance to Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitors Correlates with Up-Regulation of the MEK/Extracellular Signal-Regulated Kinase Pathway in Hepatocellular Carcinoma Cells. Journal of Pharmacology and Experimental Therapeutics 2009; 329(3): 1063 doi: 10.1124/jpet.108.147306
124
Runzhou Zhuang, Xuanyu Zhang, Di Lu, Jianguo Wang, Jianyong Zhuo, Xuyong Wei, Qi Ling, Haiyang Xie, Shusen Zheng, Xiao Xu. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c‐Myb‐regulated MEK/ERK signaling. Molecular Carcinogenesis 2019; 58(3): 366 doi: 10.1002/mc.22934
125
Mohamad H. Imam, Marina G. Silveira, Emmanouil Sinakos, Andrea A. Gossard, Roberta Jorgensen, Jill Keach, Alisha C. DeCook, Keith D. Lindor. Long-term Outcomes of Patients With Primary Biliary Cirrhosis and Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2012; 10(2): 182 doi: 10.1016/j.cgh.2011.09.013
126
Bin Sui, Jun Lv, Xiangrong Tong, Yan Li, Chengyan Wang. Simultaneous image reconstruction and lesion segmentation in accelerated MRI using multitasking learning. Medical Physics 2021; 48(11): 7189 doi: 10.1002/mp.15213
127
Lok-Sze Wong, Chun-Ming Wong. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(6): 3137 doi: 10.3390/ijms22063137
128
Eva Sticova, Milan Jirsa. ABCB4 disease: Many faces of one gene deficiency. Annals of Hepatology 2020; 19(2): 126 doi: 10.1016/j.aohep.2019.09.010
129
Aysegul Ozakyol. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology). Journal of Gastrointestinal Cancer 2017; 48(3): 238 doi: 10.1007/s12029-017-9959-0
130
Hany A. Abdel Samie, Mohd Saeed, Syed Mohd Faisal, Mohd Adnan Kausar, Mohammad A. Kamal. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma. Current Drug Metabolism 2019; 20(4): 283 doi: 10.2174/1389200220666190308134351
131
Zhicong Zhao, Zhenjun Zhao, Jianye Wang, He Zhang, Zhifeng Xi, Qiang Xia. ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.840287
132
Jaleh Varshosaz, Maryam Farzan. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12022-12041 doi: 10.3748/wjg.v21.i42.12022
133
Kazuhito Ichikawa, Yoshiaki Tagawa, Masaomi Kawai, Makoto Asamoto, Tomoyuki Shirai. Promoting Effects of Streptozotocin-induced Diabetes on Induction of Hepatic Preneoplastic Lesions by Diethylnitrosamine in Rats. Journal of Toxicologic Pathology 2010; 23(3): 125 doi: 10.1293/tox.23.125
134
Yuting Wu, Yingshi Zhang, Xiaochun Qin, Haobin Geng, Daiying Zuo, Qingchun Zhao. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacological Research 2020; 160: 105195 doi: 10.1016/j.phrs.2020.105195
135
Katsuhiro Ogawa. Molecular pathology of early stage chemically induced hepatocarcinogenesis. Pathology International 2009; 59(9): 605 doi: 10.1111/j.1440-1827.2009.02416.x
136
Eric J. Formeister, Masato Tsuchiya, Hideki Fujii, Svitlana Shpyleva, Igor P. Pogribny, Ivan Rusyn. Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2010; 692(1-2): 26 doi: 10.1016/j.mrfmmm.2010.07.013
137
Luca Quagliata, Luigi M. Terracciano. Liver Diseases and Long Non-Coding RNAs: New Insight and Perspective. Frontiers in Medicine 2014; 1 doi: 10.3389/fmed.2014.00035
138
Fa-Da Xia, Zhuo-Lu Wang, Hong-Xi Chen, Yun Huang, Jin-Dong Li, Zhi-Ming Wang, Xin-Ying Li. Differential Expression of IQGAP1/2 in Hepatocellular Carcinoma and its Relationship with Clinical Outcomes. Asian Pacific Journal of Cancer Prevention 2014; 15(12): 4951 doi: 10.7314/APJCP.2014.15.12.4951
139
Kan Toriguchi, Etsuro Hatano, Kazutaka Tanabe, Kenji Takemoto, Kojiro Nakamura, Yukinori Koyama, Satoru Seo, Kojiro Taura, Shinji Uemoto. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine‐choline deficient diet by CCAAT/enhancer‐binding protein homologous protein deficiency. Journal of Gastroenterology and Hepatology 2014; 29(5): 1109 doi: 10.1111/jgh.12481
140
Noora Kano, Elizabeth J. Want, Mark J. W. McPhail. Metabolomics in Advanced Liver Disease. Current Treatment Options in Gastroenterology 2021; 19(2): 380 doi: 10.1007/s11938-021-00347-w
141
Jin-yan Zhao, Wei Lin, Qun-chuan Zhuang, Xiao-yong Zhong, Jun Peng, Zhen-Feng Hong. Bear bile powder inhibits angiogenesis in vivo and in vitro. Chinese Journal of Integrative Medicine 2015; 21(5): 369 doi: 10.1007/s11655-015-2062-0
142
Deepali Jain, Nabeen C. Nayak, Sanjiv Saigal. Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis. European Journal of Gastroenterology & Hepatology 2012; 24(7): 840 doi: 10.1097/MEG.0b013e3283534b40
143
E. Innala, C. Andersson. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. Journal of Internal Medicine 2011; 269(5): 538 doi: 10.1111/j.1365-2796.2010.02335.x
144
Daokun Yang, Fujun Zhou, Xinwei Wang, Haili Gao, Guangyan Li, Minghui Xue. Association analysis betweenMDR1gene polymorphisms and risk of hepatocellular carcinoma in Chinese population. Biomarkers 2013; 18(3): 236 doi: 10.3109/1354750X.2013.773079
145
Jiao Li, Dan-Dan Wu, Ji-Xiang Zhang, Jing Wang, Jing-Jing Ma, Xue Hu, Wei-Guo Dong. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells. World Journal of Gastroenterology 2018; 24(17): 1901-1910 doi: 10.3748/wjg.v24.i17.1901
146
Kyuwoong Kim, Seulggie Choi, Sang Min Park. Association of fasting serum glucose level and type 2 diabetes with hepatocellular carcinoma in men with chronic hepatitis B infection: A large cohort study. European Journal of Cancer 2018; 102: 103 doi: 10.1016/j.ejca.2018.07.008
147
Alexander Gerbes, Fabien Zoulim, Herbert Tilg, Jean-François Dufour, Jordi Bruix, Valérie Paradis, Riad Salem, Markus Peck-Radosavljevic, Peter R Galle, Tim F Greten, Jean-Charles Nault, Matias A Avila. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut 2018; 67(2): 380 doi: 10.1136/gutjnl-2017-315068
148
Hao Zheng, Wei-hua Jiang, Tao Tian, Hai-song Tan, Ying Chen, Guang-lei Qiao, Jun Han, Sheng-yu Huang, Yuan Yang, Shuai Li, Zhen-guang Wang, Rong Gao, Hao Ren, Hao Xing, Jun-sheng Ni, Lin-Hui Wang, Li-jun Ma, Wei-ping Zhou. CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma. Oncotarget 2017; 8(12): 18872 doi: 10.18632/oncotarget.14770
149
Ruili Li, Hongjun Li, Yanyan Zhang, Qi Zhang, Jinli Ding, Yunfang Li. Study progression MRI findings with pathologic correlation in hepatitis B virus-associated multistage hepatocellular carcinoma. Radiology of Infectious Diseases 2015; 2(2): 94 doi: 10.1016/j.jrid.2015.08.001
150
Daniel Ansari, Inger Keussen, Roland Andersson. Positron emission tomography in malignancies of the liver, pancreas and biliary tract – indications and potential pitfalls. Scandinavian Journal of Gastroenterology 2013; 48(3): 259 doi: 10.3109/00365521.2012.704936
151
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
152
Nadia Panera, Annalisa Crudele, Ilaria Romito, Daniela Gnani, Anna Alisi. Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2017; 18(1): 99 doi: 10.3390/ijms18010099
153
Peter I. Chater, Matthew D. Wilcox, Jeffrey P. Pearson, Iain A. Brownlee. The impact of dietary fibres on the physiological processes governing small intestinal digestive processes. Bioactive Carbohydrates and Dietary Fibre 2015; 6(2): 117 doi: 10.1016/j.bcdf.2015.09.002
154
Daniel da Motta Girardi, Tatiana Strava Correa, Marcela Crosara Teixeira, Gustavo Dos Santos Fernandes. Hepatocellular Carcinoma: Review of Targeted and Immune Therapies. Journal of Gastrointestinal Cancer 2018; 49(3): 227 doi: 10.1007/s12029-018-0121-4
155
Ying Xie, Shufeng Liu, Yue Zhao, Zhanjun Guo, Jinsheng Xu. X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma. Tumor Biology 2014; 35(10): 10325 doi: 10.1007/s13277-014-2331-0
156
Nahid T. Movaghar, Saber Mojarrad, Hadi R. Shahraki, Mohammadreza Nazari, Mahtab Hadadi, Mohammad Motamedifar. Seroprevalence of Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses in End-Stage Renal Disease Patients, Southern Iran. Current Immunology Reviews 2020; 16(1): 44 doi: 10.2174/1573395516999200819164045
157
Michael C. Kew. Hepatic Iron Overload and Hepatocellular Carcinoma. Liver Cancer 2014; 3(1): 31 doi: 10.1159/000343856
158
T. Ciuleanu, I. Bazin, D. Lungulescu, L. Miron, I. Bondarenko, A. Deptala, M. Rodriguez-Torres, B. Giantonio, N.L. Fox, P. Wissel, J. Egger, M. Ding, R.N. Kalyani, R. Humphreys, M. Gribbin, W. Sun. A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma. Annals of Oncology 2016; 27(4): 680 doi: 10.1093/annonc/mdw004
159
Yang Song, Shou-Jie Jin, Lian-Hua Cui, Xiao-Jun Ji, Fu-Guo Yang. Immunomodulatory Effect of Stichopus japonicus Acid Mucopolysaccharide on Experimental Hepatocellular Carcinoma in Rats. Molecules 2013; 18(6): 7179 doi: 10.3390/molecules18067179
160
Cynthia Ju, Sean P. Colgan, Holger K. Eltzschig. Hypoxia-inducible factors as molecular targets for liver diseases. Journal of Molecular Medicine 2016; 94(6): 613 doi: 10.1007/s00109-016-1408-1
161
Sara Ashtari, Mohamad Amin Pourhoseingholi, Afsaneh Sharifian, Mohamad Reza Zali. Hepatocellular carcinoma in Asia: Prevention strategy and planning. World Journal of Hepatology 2015; 7(12): 1708-1717 doi: 10.4254/wjh.v7.i12.1708
162
Hitoshi Maruyama, Masanori Takahashi, Tadashi Sekimoto, Hidehiro Kamesaki, Taro Shimada, Fumihiko Kanai, Osamu Yokosuka. Heterogeneity of Microbubble Accumulation: A Novel Approach to Discriminate Between Well-Differentiated Hepatocellular Carcinomas and Regenerative Nodules. Ultrasound in Medicine & Biology 2012; 38(3): 383 doi: 10.1016/j.ultrasmedbio.2011.12.006
163
Blaise K-Kutala, Pierre Bedossa, Jeremie Guedj, Tarik Asselah, Michelle Martinot-Peignoux, Xavier Duval, Patrick Marcellin. Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: A retrospective clinical–pathological study. Digestive and Liver Disease 2015; 47(4): 296 doi: 10.1016/j.dld.2014.12.010
164
Mithun Rudrapal, Aniket P. Kothawade, Shahira M. Ezzat, Chukwuebuka Egbuna. Analytical Techniques in Biosciences. 2022; : 1 doi: 10.1016/B978-0-12-822654-4.00002-6
165
Jin-Soo Yoon, Hwa-Mi Kim, Anandam Kasin Yadunandam, Nan-Hee Kim, Hyun-Ah Jung, Jae-Sue Choi, Chi-Yeon Kim, Gun-Do Kim. Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: Molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response. Phytomedicine 2013; 20(11): 1013 doi: 10.1016/j.phymed.2013.03.024
166
Mohamed-Naguib Wifi, Rania A. Zayed, Nevine Fouad, Ahmed Y. Hassan, Maha A. Hussien, Mohamed G. Sokar. Association of serum growth differentiation factor 15 and hepatocellular carcinoma in Egyptian patients. The Egyptian Journal of Internal Medicine 2019; 31(1): 57 doi: 10.4103/ejim.ejim_39_18
167
Maya Venkataramani, Nancy Hutton, Paul Colombani, Robert A. Anders, Allison L. Agwu. Hepatocellular Carcinoma in a Teenager with Perinatally Acquired HIV Infection without Hepatitis B or C Coinfection: A Case Report. AIDS Patient Care and STDs 2010; 24(11): 693 doi: 10.1089/apc.2010.0038
168
Gyula Végső, Dénes Görög, Imre Fehérvári, Balázs Nemes, Attila Doros, Róbert Miklós Langer, László Kóbori. Role of Organ Transplantation in the Treatment of Malignancies – Hepatocellular Carcinoma as the Most Common Tumour Treated with Transplantation. Pathology & Oncology Research 2012; 18(1): 1 doi: 10.1007/s12253-011-9441-4
169
Ji-Yeon Lee, Suk-Yong Jang, Chung Mo Nam, Eun Seok Kang. Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-44447-1
170
Eun‐Ran Park, Sang‐Bum Kim, Jee‐San Lee, Yang‐Hyun Kim, Dong‐Hyoung Lee, Eung‐Ho Cho, Sun‐Hoo Park, Chul Ju Han, Bu‐Yeo Kim, Dong Wook Choi, Young Do Yoo, Ami Yu, Jae Won Lee, Ja June Jang, Young Nyun Park, Kyung‐Suk Suh, Kee‐Ho Lee. The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. Cancer Medicine 2017; 6(4): 749 doi: 10.1002/cam4.1042
171
Jia-Horng Kao, Pei-Jer Chen, Ding-Shinn Chen. . Advances in Cancer Research 2010; 108: 21 doi: 10.1016/B978-0-12-380888-2.00002-9
172
Robert Vincent, Arun Sanyal. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Current Pathobiology Reports 2014; 2(3): 109 doi: 10.1007/s40139-014-0049-8
173
Farida Amutova, Stefan Jurjanz, Nurlan Akhmetsadykov, Maira Kazankapova, Angelina Razafitianamaharavo, Aurélien Renard, Moldir Nurseitova, Gaukhar Konuspayeva, Matthieu Delannoy. Adsorption of organochlorinated pesticides: Adsorption kinetic and adsorption isotherm study. Results in Engineering 2023; 17: 100823 doi: 10.1016/j.rineng.2022.100823
174
Han Jak Ryu, Do Young Kim, Jun Yong Park, Hye Young Chang, Myoung Ha Lee, Kwang‐Hyub Han, Chae Yoon Chon, Sang Hoon Ahn. Clinical features and prognosis of hepatocellular carcinoma with respect to pre‐S deletion and basal core promoter mutations of hepatitis B virus Genotype C2. Journal of Medical Virology 2011; 83(12): 2088 doi: 10.1002/jmv.22238
175
Metin Cetin, Gorkem Odabas, Leon Douglas, Patrick Duriez, Pelin Balcik-Ercin, Irem Yalim-Camci, Abdulkadir Sayan, Tamer Yagci. ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells. Cells 2019; 8(3): 210 doi: 10.3390/cells8030210
176
Jia-Horng Kao. Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 2015; 29(6): 907 doi: 10.1016/j.bpg.2015.09.011
177
Angela Risch, Narek Sarkisyan, David Scherf, Hanna Jacobsson, Wolfgang Hagmann, Christoph Plass. Epigenetic Epidemiology. 2012; : 225 doi: 10.1007/978-94-007-2495-2_13
178
Christian Steinberg, Suzanne Boudreau, Felix Leveille, Marc Lamothe, Patrick Chagnon, Isabelle Boulais. Advanced Hepatocellular Carcinoma with Subtotal Occlusion of the Inferior Vena Cava and a Right Atrial Mass. Case Reports in Vascular Medicine 2013; 2013: 1 doi: 10.1155/2013/489373
179
Jin Lee, Kye-Taek Lim. Apoptotic activity of ethanol extract from Styrax Japonica Siebold et al Zuccarini in HepG2 cells. Journal of Ethnopharmacology 2010; 131(1): 210 doi: 10.1016/j.jep.2010.06.026
180
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
181
QING SHAO, PENGFEI REN, YANG LI, BO PENG, LIPING DAI, NINGJING LEI, WU YAO, GANG ZHAO, LINGGEN LI, JIANYING ZHANG. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma. International Journal of Oncology 2012; 41(3): 1061 doi: 10.3892/ijo.2012.1515
182
Jian Jun Hu, Chong Hui Li, Hong Dong Wang, Wen Li Xu, Ai Qun Zhang, Jia Hong Dong. Portal vein clamping alone confers protection against hepatic ischemia–reperfusion injury via preserving hepatocyte function in cirrhotic rats. Journal of Surgical Research 2015; 194(1): 139 doi: 10.1016/j.jss.2014.10.003
183
Mangesh Chikhale, Pampa Ch Toi, Neelaiah Siddaraju, Ramesh Ananthakrishnan. The strength of cytomorphology and efficacy of immuno‐cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine‐needle aspiration cytology. Diagnostic Cytopathology 2021; 49(7): 864 doi: 10.1002/dc.24759
184
Shane A. Wells. Quantification of Hepatic Fat and Iron with Magnetic Resonance Imaging. Magnetic Resonance Imaging Clinics of North America 2014; 22(3): 397 doi: 10.1016/j.mric.2014.04.010
185
Soungmun Kim, Seogsong Jeong, Sun Jae Park, Jooyoung Chang, Seulggie Choi, Yoosun Cho, Joseph C. Ahn, Gyeongsil Lee, Joung Sik Son, Sang Min Park. Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study. Journal of Clinical Medicine 2022; 11(10): 2865 doi: 10.3390/jcm11102865
186
Jia‐Horng Kao. Clinical Dilemmas in Primary Liver Cancer. 2011; : 18 doi: 10.1002/9781119962205.ch3
187
Julie Konfortion, Victoria H. Coupland, Hemant M. Kocher, William Allum, Melanie J. Grocock, Ruth H. Jack. Time and deprivation trends in incidence of primary liver cancer subtypes in England. Journal of Evaluation in Clinical Practice 2014; 20(4): 498 doi: 10.1111/jep.12188
188
ZHANJUN GUO, HUA YANG, CUIJU WANG, SHUFENG LIU. Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinoma. Experimental and Therapeutic Medicine 2012; 3(3): 499 doi: 10.3892/etm.2011.434
189
Ya-Sian Chang, Ya-Ting Lee, Ju-Chen Yen, Yuli C. Chang, Li-Li Lin, Wen-Ling Chan, Wei-Chiao Chang, Shyr-Yi Lin, Jan-Gowth Chang. Long Noncoding RNA NTT Context-Dependently Regulates MYB by Interacting With Activated Complex in Hepatocellular Carcinoma Cells. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.592045
190
Takashi Ohtani, Tomokazu Ishida, Kumi Ozaki, Kouki Takahashi, Masato Shimada, Eiji Kidoya. Usefulness of Electron Density Calculated from Dual Energy CT in Differential Diagnosis between Hepatocellular Carcinoma and Hepatic Hemangioma. Japanese Journal of Radiological Technology 2023; 79(12): 1337 doi: 10.6009/jjrt.2023-1387
191
L. Monfardini, P. Della Vigna, G. Bonomo, F. Orsi, M. Tullii, D. Disalvatore, S. Monfardini. Interventional oncology in the elderly: Complications and early response in liver and kidney malignancies. Journal of Geriatric Oncology 2013; 4(1): 58 doi: 10.1016/j.jgo.2012.09.001
192
KAI SONG, JUNHUA WU, CHUNPING JIANG. Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review). Oncology Reports 2013; 29(1): 3 doi: 10.3892/or.2012.2082
193
Danielle M. Tholey, Joseph Ahn. Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma. Gastroenterology Clinics of North America 2015; 44(4): 761 doi: 10.1016/j.gtc.2015.07.005
194
Jin U. Kim, I. Jane Cox, Simon D. Taylor-Robinson. The Quest for Relevant Hepatocellular Carcinoma Biomarkers. Cellular and Molecular Gastroenterology and Hepatology 2017; 4(2): 283 doi: 10.1016/j.jcmgh.2017.06.003
195
Masnoon Saiyed, Joshua Byrnes, Tushar Srivastava, Paul Scuffham, Martin Downes. Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia. Clinical Drug Investigation 2020; 40(12): 1167 doi: 10.1007/s40261-020-00983-7
196
Daniel M. Girardi, Jana Priscila M. Pacífico, Fernanda P. L. Guedes de Amorim, Gustavo dos Santos Fernandes, Marcela C. Teixeira, Allan A. L. Pereira. Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives. Pharmaceuticals 2020; 14(1): 28 doi: 10.3390/ph14010028
197
Yun Hee Kang, Na Young Ji, Chung Il Lee, Hee Gu Lee, Jae Wha Kim, Young IL Yeom, Dae Ghon Kim, Seung Kew Yoon, Jong Wan Kim, Pil Je Park, Eun Young Song. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids 2011; 40(3): 1003 doi: 10.1007/s00726-010-0729-6
198
Rui Cao, Hongguang Liu , Zhen Cheng. Radiolabeled Peptide Probes for Liver Cancer Imaging. Current Medicinal Chemistry 2020; 27(41): 6968 doi: 10.2174/0929867327666200320153837
199
Howard Lim, Ravi Ramjeesingh, Dave Liu, Vincent C Tam, Jennifer J Knox, Paul B Card, Brandon M Meyers. Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review. JNCI: Journal of the National Cancer Institute 2021; 113(2): 123 doi: 10.1093/jnci/djaa119
200
Janine Graham, Helen L. Reeves. Non‐Alcoholic Fatty Liver Disease. 2013; : 192 doi: 10.1002/9781118556153.ch17
201
Hsiang-Chun Lai, Hung-Jen Lin, Ying-Hsiu Shih, Jen-Wei Chou, Kuan-Wen Lin, Long-Bin Jeng, Sheng-Teng Huang. LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study. World Journal of Gastrointestinal Oncology 2023; 15(5): 828-842 doi: 10.4251/wjgo.v15.i5.828
202
Alexia Karen Cotte, Vanessa Cottet, Virginie Aires, Thomas Mouillot, Maud Rizk, Sandrine Vinault, Christine Binquet, Jean-Paul Pais de Barros, Patrick Hillon, Dominique Delmas. Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients. Oncotarget 2019; 10(22): 2161 doi: 10.18632/oncotarget.26738
203
James O'Connell, Siobhan Rooney. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review and meta-analysis of randomized controlled trials comparing screening methodologies. Journal of Global Health Reports 2020; 4 doi: 10.29392/001c.12924
204
K. V. Menon, A. R. Hakeem, N. D Heaton. Review article: liver transplantation for hepatocellular carcinoma – a critical appraisal of the current worldwide listing criteria. Alimentary Pharmacology & Therapeutics 2014; 40(8): 893 doi: 10.1111/apt.12922
205
Grace Chappell, Igor P. Pogribny, Kathryn Z. Guyton, Ivan Rusyn. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review. Mutation Research/Reviews in Mutation Research 2016; 768: 27 doi: 10.1016/j.mrrev.2016.03.004
206
R. N. Komarov, R. B. Alikhanov, S. V. Chernyavskiy, P. P. Kim, A. G. Yavorovskiy, R. S. Goloshchapov-aksenov. Left hemihepatectomy with thrombectomy from inferior vena cava and right atrium under cardiopulmonary bypass in patient with hepatocellular carcinoma. Khirurgiya. Zhurnal im. N.I. Pirogova 2017; (11): 82 doi: 10.17116/hirurgia20171182-84
207
John M. Page, Stephen A. Harrison. NASH and HCC. Clinics in Liver Disease 2009; 13(4): 631 doi: 10.1016/j.cld.2009.07.007
208
Xiaofei Li, Wenjun Yang, Lianqing Lou, Yongxin Chen, Shuang Wu, Guoqiang Ding. microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Digestive Diseases and Sciences 2014; 59(6): 1099 doi: 10.1007/s10620-013-3006-1
209
Ruptured HCC Presenting as Acute Abdomen in a Non-cirrhotic Patient: a Diagnostic and Management Challenge. Indian Journal of Surgery 2021; 83(4): 1032 doi: 10.1007/s12262-020-02485-4
210
Gorantla Sri Charitha, Nyshadham S.N. Chaitanya, Aramati Bindu Madhava Reddy. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 357 doi: 10.1016/B978-0-323-98807-0.00017-X
211
Changqing Zhao, Mindie H. Nguyen. Hepatocellular Carcinoma Screening and Surveillance. Journal of Clinical Gastroenterology 2016; 50(2): 120 doi: 10.1097/MCG.0000000000000446
212
Priscila Henriques da Silva, Matheus Menezes Gomes, Carla Adriana Loureiro de Matos, Ivonete Sandra de Souza e Silva, Adriano Miziara Gonzalez, Ulysses S. Torres, Gloria Maria Martinez Salazar, Giuseppe D'Ippolito. HCC Detection on Surveillance US. Journal of Ultrasound in Medicine 2021; 40(11): 2487 doi: 10.1002/jum.15637
213
Leigh Ann White, Joseph Menzin, Jonathan R. Korn, Mark Friedman, Kathy Lang, Saurabh Ray. Medical Care Costs and Survival Associated With Hepatocellular Carcinoma Among the Elderly. Clinical Gastroenterology and Hepatology 2012; 10(5): 547 doi: 10.1016/j.cgh.2011.12.031
214
Ali Soleimani, Jafar Hassanzadeh, Ali Ghanbari Motlagh, Hamidreza Tabatabaee, Elham Partovipour, Sareh Keshavarzi, Mohammad Hossein. Spatial Analysis of Common Gastrointestinal Tract Cancers in Counties of Iran. Asian Pacific Journal of Cancer Prevention 2015; 16(9): 4025 doi: 10.7314/APJCP.2015.16.9.4025
215
P. A. Shuper, M. Neuman, F. Kanteres, D. Baliunas, N. Joharchi, J. Rehm. Causal Considerations on Alcohol and HIV/AIDS -- A Systematic Review. Alcohol and Alcoholism 2010; 45(2): 159 doi: 10.1093/alcalc/agp091
216
Magdalena Śmiech, Paweł Leszczyński, Christopher Wardell, Piotr Poznański, Mariusz Pierzchała, Hiroaki Taniguchi. Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression. International Journal of Molecular Sciences 2022; 23(3): 1548 doi: 10.3390/ijms23031548
217
Hui Liu, Songhao Jia, Kun Guo, Rongkuan Li. INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma. Bioscience Reports 2022; 42(7) doi: 10.1042/BSR20221082
218
Xiangkun Wang, Xin Zhou, Junqi Liu, Zhengqian Liu, Linbo Zhang, Yizhen Gong, Jianlu Huang, Long Yu, Qiaoqi Wang, Chengkun Yang, Xiwen Liao, Tingdong Yu, Chuangye Han, Guangzhi Zhu, Xinping Ye, Tao Peng. Genome‑wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein‑coding genes in hepatocellular carcinoma. International Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4858
219
Zeinab Fazeli, Mohamad Amin Pourhoseingholi, Mohsen Vahedi, Mohammad Reza Zali. Burden of Hepatocellular Carcinoma in Asia. Asian Pacific Journal of Cancer Prevention 2012; 13(12): 5955 doi: 10.7314/APJCP.2012.13.12.5955
220
Kuo Chao Yew, Quan Rui Tan, Phei Ching Lim, Wei Yang Low, Chong Yew Lee. Assessing the impact of direct-acting antivirals on hepatitis C complications: a systematic review and meta-analysis. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(3): 1421 doi: 10.1007/s00210-023-02716-x
221
Mahmoud Abu-Amara, Orlando Cerocchi, Gurtej Malhi, Suraj Sharma, Colina Yim, Hemant Shah, David K Wong, Harry L A Janssen, Jordan J Feld. The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection. Gut 2016; 65(8): 1347 doi: 10.1136/gutjnl-2014-309099
222
C.-C. Chiu, J.-J. Wang, Y.-S. Chen, J.-J. Chen, T.-C. Tsai, C.-C. Lai, D.-P. Sun, H.-Y. Shi. Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan. European Journal of Surgical Oncology (EJSO) 2015; 41(9): 1170 doi: 10.1016/j.ejso.2015.04.023
223
Yunyun Yang, Ju Zhou, Ying Yang, Zhi Chen, Xiaodong Zheng. Systematic review and meta-analysis: dairy consumption and hepatocellular carcinoma risk. Journal of Public Health 2017; 25(6): 591 doi: 10.1007/s10389-017-0806-3
224
RESEARCH OF ADSORPTION AFLATOXINS BY TECHNICAL LIGNIN. World Science 2021; (10(71)) doi: 10.31435/rsglobal_ws/30112021/7703
225
Dong Sun, Jinghui Lu, Chunxiao Hu, Qiangbo Zhang, Xiangdong Wang, Zongli Zhang, Sanyuan Hu. Prognostic role of miR‑760 in hepatocellular carcinoma. Oncology Letters 2018;  doi: 10.3892/ol.2018.9546
226
Zhen Yang, Ruoyu Miao, Guangbing Li, Yan Wu, Simon Robson, Xiaobo Yang, Yi Zhao, Haitao Zhao, Yang Zhong. Identification of Recurrence Related microRNAs in Hepatocellular Carcinoma after Surgical Resection. International Journal of Molecular Sciences 2013; 14(1): 1105 doi: 10.3390/ijms14011105
227
Marco D'Anzeo, Luca Faloppi, Mario Scartozzi, Riccardo Giampieri, Maristella Bianconi, Michela Del Prete, Nicola Silvestris, Stefano Cascinu. The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment. Molecules 2014; 19(5): 6393 doi: 10.3390/molecules19056393
228
Xiaobin Feng, Ruocai Xu, Xilin Du, Kefeng Dou, Xiao Qin, Jun Xu, Weidong Jia, Zhiming Wang, Hongzhi Zhao, Shufa Yang, Chenyang Guo, Tianqi Liu, Kuansheng Ma. Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study. American Journal of Gastroenterology 2014; 109(12): 1891 doi: 10.1038/ajg.2014.343
229
Zi-Cheng Jiang, Xian-Mei Tang, Ying-Ren Zhao, Lei Zheng. A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population. Tumor Biology 2014; 35(12): 12345 doi: 10.1007/s13277-014-2547-z
230
Hassan Yazdanpanah, Samira Eslamizad. Biological Toxins and Bioterrorism. Toxinology 2015; : 103 doi: 10.1007/978-94-007-5869-8_11
231
Sohail Hussain, Abdulmajeed M. Jali, Saeed Alshahrani, Khairat H. M. Khairat, Rahimullah Siddiqui, Mohammad Intakhab Alam, Raisuddin Ali, Manal Mohammed, Andleeb Khan, Hamad Al Shahi, Ali Hanbashi, Marwa Qadri, Mohammad Ashafaq. Hepatoprotective and Antioxidant Effects of Nanopiperine against Cypermethrin via Mitigation of Oxidative Stress, Inflammations and Gene Expression Using qRT-PCR. International Journal of Molecular Sciences 2023; 24(20): 15361 doi: 10.3390/ijms242015361
232
Xiaodong Wen, Lacy Reynolds, Rohit S. Mulik, Soo Young Kim, Tim Van Treuren, Liem H. Nguyen, Hao Zhu, Ian R. Corbin. Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats. Gastroenterology 2016; 150(2): 488 doi: 10.1053/j.gastro.2015.10.008
233
Catherine Li, Timothy J. Chalmers, Ashley S.A. Wong, Moran Zhou, Maria B. Marinova, Michael J. Bertoldo, Lindsay E. Wu. The Stem Cell Niche during Ageing. Advances in Stem Cells and their Niches 2020; 4: 127 doi: 10.1016/bs.asn.2020.07.002
234
Binfeng Wang, Miaomiao Ma, Xiaojun Guo, Yan Yan, Lang Li. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk. Medicine 2021; 100(41): e27527 doi: 10.1097/MD.0000000000027527
235
Elisa Bustaffa, Liliana Cori, Adele Manzella, Daniela Nuvolone, Fabrizio Minichilli, Fabrizio Bianchi, Francesca Gorini. The health of communities living in proximity of geothermal plants generating heat and electricity: A review. Science of The Total Environment 2020; 706: 135998 doi: 10.1016/j.scitotenv.2019.135998
236
Alan P. Venook, Christos Papandreou, Junji Furuse, Laura Ladrón de Guevara. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective. The Oncologist 2010; 15(S4): 5 doi: 10.1634/theoncologist.2010-S4-05
237
Jarrod Bailey. An Examination of Chimpanzee Use in Human Cancer Research. Alternatives to Laboratory Animals 2009; 37(4): 399 doi: 10.1177/026119290903700410
238
CM McCarthy, M McCarthy, K O’Donoghue. Recurrent hepatocellular carcinoma in pregnancy: A case report and literature review. Obstetric Medicine 2019; 12(4): 202 doi: 10.1177/1753495X18784074
239
Wei Sang, Wei Zhang, Wenli Cui, Xinxia Li, Gulinar Abulajiang, Qiaoxin Li. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma. Tumor Biology 2015; 36(5): 3881 doi: 10.1007/s13277-014-3030-6
240
Teera Kangkhetkron, Chudchawal Juntarawijit. Factors Influencing Practice of Pesticide Use and Acute Health Symptoms among Farmers in Nakhon Sawan, Thailand. International Journal of Environmental Research and Public Health 2021; 18(16): 8803 doi: 10.3390/ijerph18168803
241
Qian Zhou, Vivian WY Lui, Winnie Yeo. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Future Oncology 2011; 7(10): 1149 doi: 10.2217/fon.11.95
242
T W Chew, X J Liu, L Liu, J M Spitsbergen, Z Gong, B C Low. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models. Oncogene 2014; 33(21): 2717 doi: 10.1038/onc.2013.240
243
Evelyn Lamy, Anke Hertrampf, Corinna Herz, Julia Schüler, Miriam Erlacher, Daniela Bertele, Adekunle Bakare, Meike Wagner, Timo Weiland, Ulrich Lauer, Oliver Drognitz, Roman Huber, Sascha Rohn, Torsten Giesemann, Volker Mersch-Sundermann, Manlio Vinciguerra. Preclinical Evaluation of 4-Methylthiobutyl Isothiocyanate on Liver Cancer and Cancer Stem Cells with Different p53 Status. PLoS ONE 2013; 8(8): e70846 doi: 10.1371/journal.pone.0070846
244
Yexiong Tan, Peiyuan Yin, Liang Tang, Wenbin Xing, Qiang Huang, Dan Cao, Xinjie Zhao, Wenzhao Wang, Xin Lu, Zhiliang Xu, Hongyang Wang, Guowang Xu. Metabolomics Study of Stepwise Hepatocarcinogenesis From the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma Diagnosis. Molecular & Cellular Proteomics 2012; 11(2): M111.010694 doi: 10.1074/mcp.M111.010694
245
Linda L. Wong, Christopher J. Kim, Sandi A. Kwee, Brenda Y. Hernandez. Alpha-fetoprotein testing for hepatocellular carcinoma may not be helpful in nonalcoholic steatohepatitis. Open Journal of Gastroenterology 2013; 3(01): 49 doi: 10.4236/ojgas.2013.31008
246
Yoshitaka Takuma, Iwadou Shota, Hirokazu Miyatake, Shuji Uematsu, Ryouichi Okamoto, Yasuyuki Araki, Hiroyuki Takabatake, Youichi Morimoto, Hiroshi Yamamoto. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma. Internal Medicine 2018; 57(4): 457 doi: 10.2169/internalmedicine.9064-17
247
Lisha Mou, Zuhui Pu, Yongxiang Luo, Ryan Quan, Yunhu So, Hui Jiang. Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1036562
248
Tran Duc Dung, Cecilia Hsuan Day, Truong Viet Binh, Chih-Hsueh Lin, Hsi-Hsien Hsu, Cheng-Chuan Su, Yueh-Min Lin, Fuu-Jen Tsai, Wei-Wen Kuo, Li-Mien Chen, Chih-Yang Huang. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K–Akt–MDM2 signaling suppression. Food and Chemical Toxicology 2012; 50(5): 1802 doi: 10.1016/j.fct.2012.01.021
249
Gary C. Kanel, Jacob Korula. Atlas of Liver Pathology. 2011; : 249 doi: 10.1016/B978-1-4377-0765-6.10010-2
250
Afsaneh Bazgir, Mehdi Agha Gholizadeh, Ayyoob Khosravi, Nader Mansour Samaei. The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular Carcinoma in an Iranian Population. Middle East Journal of Digestive Diseases 2018; 10(1): 40 doi: 10.15171/mejdd.2017.89
251
Yoshiaki Mizuguchi, Toshihiro Takizawa, Hiroshi Yoshida, Eiji Uchida. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. Hepatology Research 2016; 46(5): 391 doi: 10.1111/hepr.12606
252
David J Hughes, Talita Duarte-Salles, Sandra Hybsier, Antonia Trichopoulou, Magdalena Stepien, Krasimira Aleksandrova, Kim Overvad, Anne Tjønneland, Anja Olsen, Aurélie Affret, Guy Fagherazzi, Marie-Christine Boutron-Ruault, Verena Katzke, Rudolf Kaaks, Heiner Boeing, Christina Bamia, Pagona Lagiou, Eleni Peppa, Domenico Palli, Vittorio Krogh, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote, Hendrik Bastiaan Bueno-de-Mesquita, Petra H Peeters, Dagrun Engeset, Elisabete Weiderpass, Cristina Lasheras, Antonio Agudo, Maria-José Sánchez, Carmen Navarro, Eva Ardanaz, Miren Dorronsoro, Oskar Hemmingsson, Nicholas J Wareham, Kay-Tee Khaw, Kathryn E Bradbury, Amanda J Cross, Marc Gunter, Elio Riboli, Isabelle Romieu, Lutz Schomburg, Mazda Jenab. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. The American Journal of Clinical Nutrition 2016; 104(2): 406 doi: 10.3945/ajcn.116.131672
253
Danielle M Tholey, Ben Hornung, Charles K Enestvedt, Yiyi Chen, Willscott S Naugler, Khashayar Farsad, Nima Nabavizadeh, Barry Schlansky, Joseph Ahn, Janice H Jou. Close observation versus upfront treatment in hepatocellular carcinoma: are the exception points worth the risk?. BMJ Open Gastroenterology 2017; 4(1): e000157 doi: 10.1136/bmjgast-2017-000157
254
Silvia Ribback, Verena Sailer, Enrico Böhning, Julia Günther, Jaqueline Merz, Frauke Steinmüller, Kirsten Utpatel, Antonio Cigliano, Kristin Peters, Maria Pilo, Matthias Evert, Diego Calvisi, Frank Dombrowski. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models. International Journal of Molecular Sciences 2016; 17(10): 1618 doi: 10.3390/ijms17101618
255
Yoon-Chul Kim. Advanced Methods in Dynamic Contrast Enhanced Arterial Phase Imaging of the Liver. Investigative Magnetic Resonance Imaging 2019; 23(1): 1 doi: 10.13104/imri.2019.23.1.1
256
Nada Assi, Marc J Gunter, Duncan C Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M Sandanger, Amaia Molinuevo, Hendriek Boshuizen, Anneli Sundkvist, Tilman Kühn, Ruth Travis, Kim Overvad, Elio Riboli, Augustin Scalbert, Mazda Jenab, Vivian Viallon, Pietro Ferrari. Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort. The American Journal of Clinical Nutrition 2018; 108(1): 117 doi: 10.1093/ajcn/nqy074
257
Alexey Surov, Maciej Pech, Jazan Omari, Frank Fischbach, Robert Damm, Katharina Fischbach, Maciej Powerski, Borna Relja, Andreas Wienke. Diffusion-Weighted Imaging Reflects Tumor Grading and Microvascular Invasion in Hepatocellular Carcinoma. Liver Cancer 2021; 10(1): 10 doi: 10.1159/000511384
258
Xixia Huang, Hong Wang, Wenhong Zhang, Erli Gu. Verification of hepatitis B–related hepatocellular carcinoma predictive models to evaluate the risk of HCC in patients with liver cirrhosis under antiviral treatment. European Journal of Gastroenterology & Hepatology 2022; 34(5): 546 doi: 10.1097/MEG.0000000000002302
259
Shohei Okazaki, Kei Shibuya, Shintaro Shiba, Tomoyuki Takura, Tatsuya Ohno. Cost-Effectiveness Comparison of Carbon-Ion Radiation Therapy and Transarterial Chemoembolization for Hepatocellular Carcinoma. Advances in Radiation Oncology 2024; 9(4): 101441 doi: 10.1016/j.adro.2024.101441
260
Qian Wu, Pei Wang, Qihang Peng, Zhongcui Kang, Yiting Deng, Jiayi Li, Ying Chen, Jin Li, Feng Ge. Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker. International Journal of Molecular Sciences 2023; 24(23): 16986 doi: 10.3390/ijms242316986
261
V. Sivaramakrishnan, S. Niranjali Devaraj. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chemico-Biological Interactions 2009; 180(3): 353 doi: 10.1016/j.cbi.2009.02.004
262
Massimiliano Berretta, Elisa Garlassi, Bruno Cacopardo, Alessandro Cappellani, Giovanni Guaraldi, Stefania Cocchi, Paolo De Paoli, Arben Lleshi, Immacolata Izzi, Augusta Torresin, Pietro Di Gangi, Antonello Pietrangelo, Mariachiara Ferrari, Alessandra Bearz, Salvatore Berretta, Guglielmo Nasti, Fabrizio Di Benedetto, Luca Balestreri, Umberto Tirelli, Paolo Ventura. Hepatocellular Carcinoma in HIV-Infected Patients: Check Early, Treat Hard. The Oncologist 2011; 16(9): 1258 doi: 10.1634/theoncologist.2010-0400
263
Masako Shomura, Tatehiro Kagawa, Koichi Shiraishi, Shunji Hirose, Yoshitaka Arase, Jun Koizumi, Tetsuya Mine. Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma. World Journal of Hepatology 2014; 6(9): 670-676 doi: 10.4254/wjh.v6.i9.670
264
Nobuyuki Shimizu, Hiroshi Shiraishi, Toshikatsu Hanada. Zebrafish as a Useful Model System for Human Liver Disease. Cells 2023; 12(18): 2246 doi: 10.3390/cells12182246
265
Wenyi Liu, Lingqiao Wang, Chuanfen Zheng, Lebin Liu, Jia Wang, Daibo Li, Yao Tan, Xilong Zhao, Lixiong He, Weiqun Shu. Microcystin-LR increases genotoxicity induced by aflatoxin B1 through oxidative stress and DNA base excision repair genes in human hepatic cell lines. Environmental Pollution 2018; 233: 455 doi: 10.1016/j.envpol.2017.10.067
266
Lisha Mou, Chenyang Jia, Zijing Wu, Boyang Xin, Carmen Alicia Liang Zhen, Bailiang Wang, Yong Ni, Zuhui Pu. Clinical and Prognostic Value of PPIA, SQSTM1, and CCL20 in Hepatocellular Carcinoma Patients by Single-Cell Transcriptome Analysis. Cells 2022; 11(19): 3078 doi: 10.3390/cells11193078
267
Concetta Panebianco, Chiara Saracino, Valerio Pazienza. Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression. Tumor Biology 2014; 35(8): 7307 doi: 10.1007/s13277-014-2075-x
268
Wang Zhifang. Analysis of Risk Factors for Development of Hepatocellular Carcinoma in Chronic HBV - Infected Liver Cirrhosis Patients: A Meta-Analysis. International Journal of Immunotherapy and Cancer Research 2017; : 034 doi: 10.17352/2455-8591.000017
269
Naoki Watanabe, Koji Takai, Kenji Imai, Masahito Shimizu, Takafumi Naiki, Masahito Nagaki, Hisataka Moriwaki. Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment. Journal of Clinical Biochemistry and Nutrition 2011; 49(3): 153 doi: 10.3164/jcbn.10-149
270
Chunhua Bei, Chao Tan, Xiaonian Zhu, Zhigang Wang, Shengkui Tan. Association Between Polymorphisms in CMTM Family Genes and Hepatocellular Carcinoma in Guangxi of China. DNA and Cell Biology 2018; 37(8): 691 doi: 10.1089/dna.2018.4274
271
Shuai Xue, Fengqin Lu, Chunhui Sun, Jingjing Zhao, Honghua Zhen, Xin Li. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02176-8
272
Jinyan Zhao, Yunpeng Zhao, Hao Wang, Xing Gu, Jun Ji, Chunfang Gao. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional study. Nutrition Journal 2011; 10(1) doi: 10.1186/1475-2891-10-49
273
Shital S. Panchal, Somsuvra B. Ghatak, Abhishek B. Jha, Raoul Onattu. Reduction of liver tumerogenic effect of N-nitrosodiethylamine by treatment with ɣ-oryzanol in Balb/C mice. Environmental Toxicology and Pharmacology 2017; 56: 86 doi: 10.1016/j.etap.2017.08.006
274
Koushik Sarker , Avijit Ghosh , Abhijit Saha, Suvasish Mishra, Subrata Sen. Pharmacophore Based Design of Probable FGFR-1 Inhibitors from the 3D Crystal Structure of Infigratinib - A Drug Used in the Treatment of Cholangiocarcinomas. Letters in Drug Design & Discovery 2022; 19(4): 314 doi: 10.2174/1570180818666211007113720
275
Kai Bai, Yi Cao, Chao Huang, Jianwei Chen, Xiaojin Zhang, Yi Jiang. Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 Months. Medicine 2016; 95(2): e2493 doi: 10.1097/MD.0000000000002493
276
Lutz Schomburg, David J. Hughes. The missing link? The potential role of selenium in the development of liver cancer and significance for the general population. Expert Review of Gastroenterology & Hepatology 2017; 11(8): 707 doi: 10.1080/17474124.2017.1320219
277
Gang Huang, Eric C. H. Lai, Wan Yee Lau, Wei-ping Zhou, Feng Shen, Ze-ya Pan, Si-yuan Fu, Meng-chao Wu. Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels. Annals of Surgery 2013; 257(3): 490 doi: 10.1097/SLA.0b013e318262b218
278
Ehab Abdel-Atti. HCC Burden in Egypt. Gastroenterology & Hepatology : Open Access 2015; 2(3) doi: 10.15406/ghoa.2015.02.00045
279
Magdalena Stepien, Veronika Fedirko, Talita Duarte-Salles, Pietro Ferrari, Heinz Freisling, Elisabeth Trepo, Antonia Trichopoulou, Christina Bamia, Elisabete Weiderpass, Anja Olsen, Anne Tjønneland, Kim Overvad, Marie-Christine Boutron-Ruault, Guy Fagherazzi, Antoine Racine, Tilman Kühn, Rudolf Kaaks, Krasimira Aleksandrova, Heiner Boeing, Pagona Lagiou, Vassiliki Benetou, Dimitrios Trichopoulos, Domenico Palli, Sara Grioni, Rosario Tumino, Alessio Naccarati, Salvatore Panico, H. Bas. Bueno-de-Mesquita, Petra H. Peeters, Eiliv Lund, J. Ramón Quirós, Osmel Companioni Nápoles, María-José Sánchez, Miren Dorronsoro, José María Huerta, Eva Ardanaz, Bodil Ohlsson, Klas Sjöberg, Mårten Werner, Hanna Nystrom, Kay-Tee Khaw, Timothy J. Key, Marc Gunter, Amanda Cross, Elio Riboli, Isabelle Romieu, Mazda Jenab. Prospective association of liver function biomarkers with development of hepatobiliary cancers. Cancer Epidemiology 2016; 40: 179 doi: 10.1016/j.canep.2016.01.002
280
Fuqing Gao, Yun Li, Haiqing Zhao, Yannei Liang, Zhe Liu. Sub-chronic, low dose co-exposure to Aflatoxin B1 and Microcystin-LR in C57BL/6 mice significantly alters the cytokine response in serum and liver. CyTA - Journal of Food 2022; 20(1): 271 doi: 10.1080/19476337.2022.2130436
281
Santu Kumar Samanta, Shubhadeep Adak, Tridib Tripathy. Adsorption studies of toxic organic pesticides from aqueous medium by sodium alginate‐cl‐poly (allyl amine‐co‐acrylic acid)/copper oxide nanocomposite hydrogel: Isotherms, kinetics, and thermodynamics. Polymer Engineering & Science 2024; 64(4): 1620 doi: 10.1002/pen.26648
282
Shahid A. Khan, Mireille B. Toledano, Abigail Zabron, Mehtan Ahmed, Simon D. Taylor‐Robinson. Clinical Dilemmas in Primary Liver Cancer. 2011; : 24 doi: 10.1002/9781119962205.ch4
283
Benyuan Deng, Fei Liu, Yonggang Wei, Limei Luo, Xi Chen, Lvnan Yan, Bo Li. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population. Tumor Biology 2013; 34(1): 293 doi: 10.1007/s13277-012-0550-9
284
Mona Abu El Makarem. An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma. Hepatitis Monthly 2012; 12(10 HCC) doi: 10.5812/hepatmon.6122
285
Junyu Huo, Xinyi Fan, Bingxin Qi, Peng Sun. A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.771819
286
DONG KEUN SEOK, SAE YOON KEE, SOON YOUNG KO, JUNG HWA LEE, HYE YOUNG KIM, IN SUN KIM, HEE YEON SEO. Leukemia cutis in a patient with acute monocytic leukemia diagnosed simultaneously with hepatocellular carcinoma: A case study. Oncology Letters 2013; 6(5): 1319 doi: 10.3892/ol.2013.1580
287
Defne Bayik, Adam J. Lauko, Gustavo A. Roversi, Emily Serbinowski, Lou-Anne Acevedo-Moreno, Christopher Lanigan, Mushfig Orujov, Alice Lo, Tyler J. Alban, Adam Kim, Daniel J. Silver, Laura E. Nagy, J. Mark Brown, Daniela S. Allende, Federico N. Aucejo, Justin D. Lathia. Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75881-1
288
Aditi Varshney, Jiban J. Panda, Avishek K. Singh, Nitin Yadav, Chhagan Bihari, Subhrajit Biswas, Shiv K. Sarin, Virander S. Chauhan. Targeted delivery of microRNA‐199a‐3p using self‐assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Hepatology 2018; 67(4): 1392 doi: 10.1002/hep.29643
289
Xiao-Fei Li, Hua-Bin He, Yan-Shuang Zhu, Jin-Ke He, Wei-Wei Ye, Yong-Xin Chen, Lian-Qing Lou. Association Between the c.3751G>A Genetic Variant of MDR1 and Hepatocellular Carcinoma Risk in a Chinese Han Population. Asian Pacific Journal of Cancer Prevention 2013; 14(9): 5361 doi: 10.7314/APJCP.2013.14.9.5361
290
Xiao-Lian Zhang, Yu Lu, Shi Yang, Qi-Liu Peng, Jian Wang, Li Xie, Yan Deng, Yu He, Tai-Jie Li, Xue Qin, Shan Li. An Updated Meta-analysis Between the Association of XRCC1 Arg399Gln Polymorphism and Hepatocellular Carcinoma Risk. Asian Pacific Journal of Cancer Prevention 2014; 15(7): 3273 doi: 10.7314/APJCP.2014.15.7.3273
291
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris, Oronzo Brunetti. Immunotherapeutic approaches for hepatocellular carcinoma. Oncotarget 2017; 8(20): 33897 doi: 10.18632/oncotarget.15406
292
Miny Samuel, Pierce K-H Chow, Edwin Chan Shih-Yen, David Machin, Khee-Chee Soo. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2009;  doi: 10.1002/14651858.CD001199.pub2
293
Xiaoyan Liang, Ge Xu, Qing Gao, Xiaohong Tao. LKB1 expression reverses the tumorigenicity of L02 cells. Oncology Reports 2016; 36(2): 1055 doi: 10.3892/or.2016.4900
294
Allisson B. Justino, Rodrigo M. Florentino, Andressa França, Antonio C. M. L. Filho, Rodrigo R. Franco, André L. Saraiva, Matheus C. Fonseca, Maria F. Leite, Foued Salmen Espindola, Walid Elfalleh. Alkaloid and acetogenin-rich fraction from Annona crassiflora fruit peel inhibits proliferation and migration of human liver cancer HepG2 cells. PLOS ONE 2021; 16(7): e0250394 doi: 10.1371/journal.pone.0250394
295
Xi Wang, Xuelong Zhang, Bing Qiu, Yinhua Tang, He Sun, Hongfei Ji, Yan Liu, Lijun Shi, Guang Song, Youlin Yang. MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus‐related hepatocellular carcinoma in a northeast Han Chinese population. Liver International 2012; 32(7): 1172 doi: 10.1111/j.1478-3231.2012.02787.x
296
Gregory C Connolly, Saman Safadjou, Randeep Kashyap, Rui Chen, Mark S Orloff, Aram F Hezel. Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-9
297
Mi Na Kim, Jung Oh Kim, Seung Min Lee, Hana Park, Ju Ho Lee, Kyu Sung Rim, Seong Gyu Hwang, Nam Keun Kim, Seung Up Kim. Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma. PLOS ONE 2016; 11(9): e0162279 doi: 10.1371/journal.pone.0162279
298
Stella Sun, Ronnie T. P. Poon, Nikki P. Lee, Chun Yeung, K. L. Chan, Irene O. L. Ng, Philip J. R. Day, John M. Luk. Proteomics of Hepatocellular Carcinoma: Serum Vimentin As a Surrogate Marker for Small Tumors (≤2 cm). Journal of Proteome Research 2010; 9(4): 1923 doi: 10.1021/pr901085z
299
Junping Ao, Jiao Meng, Lei Zhu, Huizhen Nie, Chenchen Yang, Jinjun Li, Jianren Gu, Qiushi Lin, Weiwen Long, Xiaoqun Dong, Chao Li. Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Molecular Oncology 2012; 6(5): 507 doi: 10.1016/j.molonc.2012.06.005
300
XIAOLEI LI, ZHAOXU YANG, WENJIE SONG, LIANG ZHOU, QINGJUN LI, KAISHAN TAO, JINGSHI ZHOU, XING WANG, ZHIGANG ZHENG, NAN YOU, KEFENG DOU, HAIMIN LI. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. International Journal of Oncology 2013; 43(3): 793 doi: 10.3892/ijo.2013.1992
301
Mohammad Nurul Amin, Md. Saddam Hussain, Md. Shahid Sarwar, Md. Mizanur Rahman Moghal, Abhijit Das, Mohammad Zahid Hossain, Jakir Ahmed Chowdhury, Md. Shalahuddin Millat, Mohammad Safiqul Islam. How the association between obesity and inflammation may lead to insulin resistance and cancer. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2): 1213 doi: 10.1016/j.dsx.2019.01.041
302
Maíra Luciana Marconcini, Leonardo Fayad, Maria Beatriz Cacese Shiozawa, Esther Buzaglo Dantas-Correa, Leonardo de Lucca Schiavon, Janaína Luz Narciso-Schiavon. Autoantibody profile in individuals with chronic hepatitis C. Revista da Sociedade Brasileira de Medicina Tropical 2013; 46(2): 147 doi: 10.1590/0037-8682-0039-2013
303
Jiao-Jiao Hu, Wei Song, Shao-Dan Zhang, Xiao-Hui Shen, Xue-Mei Qiu, Hua-Zhang Wu, Pi-Hai Gong, Sen Lu, Zhu-Jiang Zhao, Ming-Liang He, Hong Fan. HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Scientific Reports 2016; 6(1) doi: 10.1038/srep23521
304
Dalvinder S Mandair, Roberta E Rossi, Marinos Pericleous, Tara Whyand, Martyn Caplin. The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014; 8(4): 369 doi: 10.1586/17474124.2014.894879
305
Xiaoqian Huang, Li Zhou, Zhiyuan Gong. Liver tumor models in transgenic zebrafish: an alternative in vivo approach to study hepatocarcinogenes. Future Oncology 2012; 8(1): 21 doi: 10.2217/fon.11.137
306
Shengyu Huang, Yong Xia, Zhengqing Lei, Qifei Zou, Jun Li, Tian Yang, Kui Wang, Zhenlin Yan, Xuying Wan, Feng Shen. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma. Journal of the American College of Surgeons 2017; 224(3): 283 doi: 10.1016/j.jamcollsurg.2016.11.009
307
Yoshitaka Takuma, Hiroyuki Takabatake, Youichi Morimoto, Nobuyuki Toshikuni, Takahisa Kayahara, Yasuhiro Makino, Hiroshi Yamamoto. Comparison of Combined Transcatheter Arterial Chemoembolization and Radiofrequency Ablation with Surgical Resection by Using Propensity Score Matching in Patients with Hepatocellular Carcinoma within Milan Criteria. Radiology 2013; 269(3): 927 doi: 10.1148/radiol.13130387
308
Jan Gran, Ragnar Gunnarsson, Nils-Jørgen Mørk. En mann med erytrodermi, muskelsvakhet og vekttap. Tidsskrift for Den norske legeforening 2009; 129(21): 2240 doi: 10.4045/tidsskr.09.0184
309
Sabrina Schlesinger, Krasimira Aleksandrova, Tobias Pischon, Veronika Fedirko, Mazda Jenab, Elisabeth Trepo, Paolo Boffetta, Christina C. Dahm, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Guy Fagherazzi, Marie‐Christine Boutron‐Ruault, Franck Carbonnel, Rudolf Kaaks, Annekatrin Lukanova, Heiner Boeing, Antonia Trichopoulou, Christina Bamia, Pagona Lagiou, Domenico Palli, Sara Grioni, Salvatore Panico, Rosario Tumino, Paolo Vineis, Bueno‐de‐Mesquita HB, Saskia van den Berg, Petra H.M. Peeters, Tonje Braaten, Elisabete Weiderpass, J. Ramón Quirós, Noémie Travier, María‐José Sánchez, Carmen Navarro, Aurelio Barricarte, Miren Dorronsoro, Björn Lindkvist, Sara Regner, Mårten Werner, Malin Sund, Kay‐Tee Khaw, Nicholas Wareham, Ruth C. Travis, Teresa Norat, Petra A. Wark, Elio Riboli, Ute Nöthlings. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. International Journal of Cancer 2013; 132(3): 645 doi: 10.1002/ijc.27645
310
Duminda Suraweera, Peter Konyn, Thomas Vu, Sammy Saab. Clinical Epidemiology of Chronic Liver Diseases. 2019; : 229 doi: 10.1007/978-3-319-94355-8_15
311
Manuela Cabiati, Melania Gaggini, Paolo De Simone, Silvia Del Ry. Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity. Clinical and Experimental Medicine 2021; 21(2): 269 doi: 10.1007/s10238-020-00672-x
312
P. C Yadala, A H M Viswanath Swamy. CHEMO PREVENTIVE EFFECT OF PIPERINE IN N-NITROSODIETHYLAMINEINDUCED AND PHENOBARBITAL PROMOTED EXPERIMENTAL RAT HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2017; 54(05): 41 doi: 10.53879/id.54.05.10813
313
Erin C. Connolly, Koenraad Van Doorslaer, Leslie E. Rogler, Charles E. Rogler. Overexpression of miR-21 Promotes an In vitro Metastatic Phenotype by Targeting the Tumor Suppressor RHOB. Molecular Cancer Research 2010; 8(5): 691 doi: 10.1158/1541-7786.MCR-09-0465
314
Linhe Wang, Xiangchao Ling, Caihui Zhu, Zhiheng Zhang, Ziming Wang, Shanzhou Huang, Yunhua Tang, Shujiao He, Zhiyong Guo, Xiaoshun He. Upregulated Seizure-Related 6 Homolog-Like 2 Is a Prognostic Predictor of Hepatocellular Carcinoma. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/7318703
315
Dan Liu, Daniel Y. T. Fong, Albert C. Y. Chan, Ronnie T. P. Poon, Pek-Lan Khong. Hepatocellular Carcinoma: Surveillance CT Schedule after Hepatectomy Based on Risk Stratification. Radiology 2015; 274(1): 133 doi: 10.1148/radiol.14132343
316
Tyler Gorham, Elisabeth Dowling Root, Yuanyuan Jia, C.K. Shum, Jiyoung Lee. Relationship between cyanobacterial bloom impacted drinking water sources and hepatocellular carcinoma incidence rates. Harmful Algae 2020; 95: 101801 doi: 10.1016/j.hal.2020.101801
317
Colleen S. Curran, Elad Sharon. PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma. Seminars in Oncology 2017; 44(6): 428 doi: 10.1053/j.seminoncol.2017.12.001
318
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors. Biomedicines 2023; 11(10): 2761 doi: 10.3390/biomedicines11102761
319
Mahitha Lampimukhi, Tabarak Qassim, Rakshaya Venu, Nivedita Pakhala, Suchita Mylavarapu, Tharindu Perera, Beeran S Sathar, Arun Nair. A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma. Cureus 2023;  doi: 10.7759/cureus.49429
320
Yan Xu, Li Liu, Jibin Liu, Yixin Zhang, Jian Zhu, Jianguo Chen, Sheng Liu, Zheng Liu, Haibin Shi, Hongbing Shen, Zhibin Hu. A potentially functional polymorphism in the promoter region of miR‐34b/c is associated with an increased risk for primary hepatocellular carcinoma. International Journal of Cancer 2011; 128(2): 412 doi: 10.1002/ijc.25342
321
A.D. Jones, J.C. Wilton. Can intra-operative fluorescence play a significant role in hepatobiliary surgery?. European Journal of Surgical Oncology 2017; 43(9): 1622 doi: 10.1016/j.ejso.2017.02.015
322
Sung Hwan Cho, Kyoungjune Pak, Dae Cheon Jeong, Myoung‐Eun Han, Sae‐Ock Oh, Yun Hak Kim. The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma. Journal of Cellular Biochemistry 2019; 120(3): 4140 doi: 10.1002/jcb.27699
323
Mehdi Sabzichi, Omolbanin Oladpour, Jamal Mohammadian, Mohsen Rashidi, Mahla Hosseinzadeh, Alireza Mardomi, Bahman Ramezani, Marjan Ghorbani, Fatemeh Ramezani. Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG2 cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(12): 2429 doi: 10.1007/s00210-021-02164-5
324
Xuehong Chen, Yantao Han, Songmei Zhan, Chunbo Wang, Shouguo Chen. Tegillarca granosa Extract Haishengsu Induces Apoptosis in Human Hepatocellular Carcinoma Cell Line BEL-7402 Via Fas-Signaling Pathways. Cell Biochemistry and Biophysics 2015; 71(2): 837 doi: 10.1007/s12013-014-0271-3
325
Andrew Bang, Laura A. Dawson. Radiotherapy for HCC: Ready for prime time?. JHEP Reports 2019; 1(2): 131 doi: 10.1016/j.jhepr.2019.05.004
326
Youwu Hao, Yang Zhang, Hongfei Ni, Jufang Gao, Yun Yang, Wenping Xu, Liming Tao. Evaluation of the cytotoxic effects of glyphosate herbicides in human liver, lung, and nerve. Journal of Environmental Science and Health, Part B 2019; 54(9): 737 doi: 10.1080/03601234.2019.1633215
327
Li Weng, Juan Du, Qinghui Zhou, Binbin Cheng, Jun Li, Denghai Zhang, Changquan Ling. Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection. Molecular Cancer 2012; 11(1) doi: 10.1186/1476-4598-11-39
328
Shao-Cheng Zhu, Yue-Hua Liu, Yi Wei, Lin-Lin Li, She-Wei Dou, Ting-Yi Sun, Da-Peng Shi. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging. World Journal of Gastroenterology 2018; 24(8): 929-940 doi: 10.3748/wjg.v24.i8.929
329
Kurt Sartorius, Leo Swadling, Ping An, Julia Makarova, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020; 12(7): 746 doi: 10.3390/v12070746
330
Yonghua Niu, Tairi Huang, Feng Lian, Fenghua Li. Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis. Tumor Biology 2013; 34(6): 3667 doi: 10.1007/s13277-013-0948-z
331
E.J. Monroe, M.J. Kogut, C.R. Ingraham, S.W. Kwan, D.S. Hippe, S.A. Padia. Outcomes of emergent embolisation of ruptured hepatocellular carcinoma in a western population. Clinical Radiology 2015; 70(7): 730 doi: 10.1016/j.crad.2015.03.007
332
Jinhwan Kim, Joho Yun, Kwanghyun Kim, Nah Ihm Kim, Hee Joon Kim, Jong-Hyun Lee. Ex-Vivo Identification of Tumor From Parenchyma in Human Liver Using Electrochemical Impedance Spectroscopy on a Needle. IEEE Sensors Journal 2020; 20(23): 14042 doi: 10.1109/JSEN.2020.3008722
333
M. Eslam, T. Kawaguchi, J. A. Del Campo, M. Sata, M. Abo-Elneen Khattab, M. Romero-Gomez. Use of HOMA-IR in hepatitis C. Journal of Viral Hepatitis 2011; 18(10): 675 doi: 10.1111/j.1365-2893.2011.01474.x
334
XIA YING, YUE ZHAO, JUN-LAN WANG, XIA ZHOU, JING ZHAO, CHEN-CHEN HE, XI-JING GUO, GUI-HUA JIN, LI-JUAN WANG, QING ZHU, SU-XIA HAN. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Oncology Reports 2014; 32(4): 1550 doi: 10.3892/or.2014.3367
335
Shrinivas Sharma, Lakshmi KS, V. Chitra, I. Aparna Lakshmi, M. Pharm. Anticarcinogenic Activity of Allylmercaptocaptopril Against Aflatoxin-B1 Induced Liver Carcinoma in Rats. Electronic Journal of General Medicine 2011; 8(1): 46 doi: 10.29333/ejgm/82696
336
Su Pin Choo, Wan Ling Tan, Brian K. P. Goh, Wai Meng Tai, Andrew X. Zhu. Comparison of hepatocellular carcinoma in Eastern versus Western populations. Cancer 2016; 122(22): 3430 doi: 10.1002/cncr.30237
337
Gang Huang, Wan Yee Lau, Zhen-Guang Wang, Ze-Ya Pan, Sheng-Xian Yuan, Feng Shen, Wei-Ping Zhou, Meng-Chao Wu. Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma. Annals of Surgery 2015; 261(1): 56 doi: 10.1097/SLA.0000000000000858
338
Gary C. Kanel. Atlas of Liver Pathology. 2024; : 347 doi: 10.1016/B978-0-323-82533-7.00012-0
339
Richard H. Hinton, Paul Grasso, Timothy C. Marrs. General, Applied and Systems Toxicology. 2009;  doi: 10.1002/9780470744307.gat068
340
Ping Lu, Hefen Sun, Lixing Zhang, Helei Hou, Lin Zhang, Fangyu Zhao, Chao Ge, Ming Yao, Tingpu Wang, Jinjun Li. Isocorydine Targets the Drug-Resistant Cellular Side Population through PDCD4-Related Apoptosis in Hepatocellular Carcinoma. Molecular Medicine 2012; 18(7): 1136 doi: 10.2119/molmed.2012.00055
341
Hassan Yazdanpanah, Samira Eslamizad. Toxinology. 2014; : 1 doi: 10.1007/978-94-007-6645-7_11-1
342
Michele Di Martino, Luca Saba, Sandro Bosco, Massimo Rossi, Kirchin A. Miles, Rossella Di Miscio, Concetta Valentina Lombardo, Elisabetta Tamponi, Mario Piga, Carlo Catalano. Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings. European Radiology 2014; 24(7): 1446 doi: 10.1007/s00330-014-3173-2
343
Brad Q. Starley, Christopher J. Calcagno, Stephen A. Harrison. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 2010; 51(5): 1820 doi: 10.1002/hep.23594
344
Renumathy Dhanasekaran, Roniel Cabrera. Primary Liver Cancer. 2012; : 263 doi: 10.1007/978-1-61779-863-4_14
345
Jing Sun, Chan Zhang, Yong-Li Bao, Yin Wu, Zhong-Liang Chen, Chun-Lei Yu, Yan-Xin Huang, Ying Sun, Li-Hua Zheng, Xue Wang, Yu-Xin Li. Parthenolide-Induced Apoptosis, Autophagy and Suppression of Proliferation in HepG2 Cells. Asian Pacific Journal of Cancer Prevention 2014; 15(12): 4897 doi: 10.7314/APJCP.2014.15.12.4897
346
Randy Chung, Sahil Mittal. Managing Gastrointestinal Complications of Diabetes. 2017; : 83 doi: 10.1007/978-3-319-48662-8_6
347
Ben Ariff, Claire R Lloyd, Sameer Khan, Mohamed Shariff, Andrew V Thillainayagam, Devinder S Bansi, Shahid A Khan, Simon D Taylor-Robinson, Adrian KP Lim. Imaging of liver cancer. World Journal of Gastroenterology 2009; 15(11): 1289-1300 doi: 10.3748/wjg.15.1289
348
Laura E. Martínez-Gómez, Norberto C. Chávez-Tapia, Ana I. Burguete-García, Nancy Aguilar-Olivos, Vicente Madrid-Marina, Margarita Román-Bahena, Citlalli Orbe-Orihuela, Uribe Misael, Nahum Méndez-Sánchez. IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. Annals of Hepatology 2012; 11(6): 876 doi: 10.1016/S1665-2681(19)31413-9
349
WEI LIN, JINYAN ZHAO, ZHIYUN CAO, QUNCHUAN ZHUANG, LIANGPU ZHENG, QIAOYAN CAI, DAXIN CHEN, LILI WANG, ZHENFENG HONG, JUN PENG. Livistona chinensis seed suppresses hepatocellular carcinoma growth through promotion of mitochondrial-dependent apoptosis. Oncology Reports 2013; 29(5): 1859 doi: 10.3892/or.2013.2319
350
Utz Settmacher, Silke Schüle, Ahmed Zidan, Hubert Scheuerlein, Falk Rauchfuss. Epidemiological Pattern of Hepatitis B and Hepatitis C as Etiological Agents for Hepatocellular Carcinoma in Iran and Worldwide. Hepatitis Monthly 2012; 12(10) doi: 10.5812/hepatmon.6894
351
Su Youn Nam. Obesity-Related Digestive Diseases and Their Pathophysiology. Gut and Liver 2017; 11(3): 323 doi: 10.5009/gnl15557
352
Sheng‐Hsuan Lin, Yen‐Tsung Huang, Hwai‐I Yang. On identification of agonistic interaction: Hepatitis B and C interaction on hepatocellular carcinoma. Statistics in Medicine 2019; 38(13): 2467 doi: 10.1002/sim.8123
353
Jonggi Choi, Lewis R. Roberts. Statins and metformin for chemoprevention of hepatocellular carcinoma. Clinical Liver Disease 2016; 8(2): 48 doi: 10.1002/cld.568
354
Georgi Kirovski, Axel P. Stevens, Barbara Czech, Katja Dettmer, Thomas S. Weiss, Peter Wild, Arndt Hartmann, Anja K. Bosserhoff, Peter J. Oefner, Claus Hellerbrand. Down-Regulation of Methylthioadenosine Phosphorylase (MTAP) Induces Progression of Hepatocellular Carcinoma via Accumulation of 5′-Deoxy-5′-Methylthioadenosine (MTA). The American Journal of Pathology 2011; 178(3): 1145 doi: 10.1016/j.ajpath.2010.11.059
355
Jack Leslie, Jill E. Hunter, Amy Collins, Amelia Rushton, Lauren G. Russell, Erik Ramon‐Gil, Maja Laszczewska, Misti McCain, Marco Y. W. Zaki, Amber Knox, Yixin Seow, Laura Sabater, Daniel Geh, Neil D. Perkins, Helen L. Reeves, Dina Tiniakos, Derek A. Mann, Fiona Oakley. c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis. Hepatology 2023; 78(4): 1050 doi: 10.1002/hep.32781
356
Rory L. O’Donohoe, Richard G. Kavanagh, Alexis M. Cahalane, Diarmaid D. Houlihan, Jeffrey W. McCann, Edmund Ronan Ryan. C-arm cone-beam CT parenchymal blood volume imaging for transarterial chemoembolization of hepatocellular carcinoma: implications for treatment planning and response. European Radiology Experimental 2019; 3(1) doi: 10.1186/s41747-019-0099-0
357
Jian Gao. Association of MDR1 gene polymorphisms with the risk of hepatocellular carcinoma in the Chinese Han population. Brazilian Journal of Medical and Biological Research 2013; 46(3): 311 doi: 10.1590/1414-431X20132774
358
Mohieldin M. Youssef , Mai F. Tolba, Noha N. Badawy, Andrew W. Liu, Eman El-Ahwany, Amani E. Khalifa, Suher Zada, Ashraf B. Abdel-Naim. Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells. Scientific Reports 2016; 6(1) doi: 10.1038/srep30717
359
Ying Xie, Shufeng Liu, Yufei Zhao, Lan Zhang, Yue Zhao, Binghui Liu, Zhanjun Guo, Isabelle A Chemin. Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma. PLOS ONE 2015; 10(7): e0133393 doi: 10.1371/journal.pone.0133393
360
Sa’ed H. Zyoud. Global scientific trends on aflatoxin research during 1998–2017: a bibliometric and visualized study. Journal of Occupational Medicine and Toxicology 2019; 14(1) doi: 10.1186/s12995-019-0248-7
361
Mutlay Sayan, Nikhil Yegya-Raman, Stephanie H. Greco, Bin Gui, Andrew Zhang, Anupama Chundury, Miral S. Grandhi, Howard S. Hochster, Timothy J. Kennedy, Russell C. Langan, Usha Malhotra, Vinod K. Rustgi, Mihir M. Shah, Kristen R. Spencer, Darren R. Carpizo, John L. Nosher, Salma K. Jabbour. Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00345
362
Sulaiman S. Alhudaithi, Mohd Abul Kalam, Lama Binobaid, Raisuddin Ali, Mohammed M. Almutairi, Wajhul Qamar, Hessa Bin Hithlayn, Atheer Almutairi, Abdullah K. Alshememry. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line. Saudi Pharmaceutical Journal 2024; 32(5): 102064 doi: 10.1016/j.jsps.2024.102064
363
Zhanjun Guo, Chensi Wu, Xiaoling Wang, Cuiju Wang, Ruixing Zhang, Baoen Shan. A polymorphism at the miR‐502 binding site in the 3′‐untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome. International Journal of Cancer 2012; 131(6): 1318 doi: 10.1002/ijc.27352
364
Hideaki Miura, Takaaki Kawaguchi, Masakazu Takazoe, Shigehiro Kitamura, Haruki Yamada. Hepatocellular Carcinoma and Crohn's Disease: A Case Report and Review. Internal Medicine 2009; 48(10): 815 doi: 10.2169/internalmedicine.48.1866
365
Hashem B. El-Serag. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma. Gastroenterology 2012; 142(6): 1264 doi: 10.1053/j.gastro.2011.12.061
366
Nisha Susan Thomas, Kiran George, Nalini Namasivayam. Molecular aspects and chemoprevention of dimethylaminoazobenzene‐induced hepatocarcinogenesis: A review. Hepatology Research 2016; 46(1): 72 doi: 10.1111/hepr.12569
367
Tohru Niwa, Toshikazu Ushijima. Epigenetics and Cancer, Part B. Advances in Genetics 2010; 71: 41 doi: 10.1016/B978-0-12-380864-6.00002-X
368
Pengfei Sun, Zhongchao Li, Bo Zhang. Characterization of disease-associated microbiota in hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2023; 19(4): 881 doi: 10.4103/jcrt.jcrt_139_22
369
Yong-Qiang Ren, Ju-Qiang Han, Jian-Biao Cao, Shao-Xiang Li, Gong-Ren Fan. Association of MDR1 Gene Polymorphisms with Susceptibility to Hepatocellular Carcinoma in the Chinese Population. Asian Pacific Journal of Cancer Prevention 2012; 13(11): 5451 doi: 10.7314/APJCP.2012.13.11.5451
370
Anh Le Tuan Nguyen, Christopher Leigh Blizzard, Kwang Chien Yee, Andrew John Palmer, Barbara de Graaff. Survival of primary liver cancer for people from culturally and linguistically diverse backgrounds in Australia. Cancer Epidemiology 2022; 81: 102252 doi: 10.1016/j.canep.2022.102252
371
Monika Pazgan-Simon, Michał Kukla, Jolanta Zuwała-Jagiełło, Aleksandra Derra, Martyna Bator, Tomasz Menżyk, Andrzej Lekstan, Ewa Grzebyk, Krzysztof Simon, Matias A. Avila. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC). PLOS ONE 2020; 15(1): e0227459 doi: 10.1371/journal.pone.0227459
372
Haifei Yu, Wanyu Deng, Shuo Chen, Bo Qin, Yongxuan Yao, Changlin Zhou, Min Guo. Strongylocentrotus nudus egg polysaccharide (SEP) suppresses HBV replication via activation of TLR4-induced immune pathway. International Journal of Biological Macromolecules 2023; 245: 125539 doi: 10.1016/j.ijbiomac.2023.125539
373
Dafina Nikolova, Viktorija Chalovska, Magdalena Genadieva Ivanova, Emilija Nikolovska, Ance Volkanovska, Nikola Orovchanec, Slavica Kostadinova Kunovska, Gordana Petrushevska, Vesna Janevska. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma. PRILOZI 2018; 39(2-3): 21 doi: 10.2478/prilozi-2018-0038
374
Yang Liu, Aiqun Zhang, Yu Liu, Jiahong Dong. Association analysis between the c.1804C>A genetic polymorphism of XRCC1 gene and risk of hepatocellular carcinoma in Chinese population. Medical Oncology 2014; 31(3) doi: 10.1007/s12032-014-0854-2
375
Xin Wan, Ci Cheng, Zhe Lin, Runqiu Jiang, Wei Zhao, Xin Yan, Junwei Tang, Kun Yao, Beicheng Sun, Yun Chen. The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells. Oncotarget 2015; 6(11): 8822 doi: 10.18632/oncotarget.3558
376
Jiarui Li, Lei Xian, Ruipeng Zheng, Yue Wang, Xiaoqiang Wan, Ying Liu. Canthaxanthin shows anti-liver aging and anti-liver fibrosis effects by down-regulating inflammation and oxidative stress in vivo and in vitro. International Immunopharmacology 2022; 110: 108942 doi: 10.1016/j.intimp.2022.108942
377
Bibek Aryal, Munekazu Yamakuchi, Toshiaki Shimizu, Jun Kadono, Akira Furoi, Kentaro Gejima, Teruo Komokata, Teruto Hashiguchi, Yutaka Imoto. Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/9142672
378
Jieun Jang, Dae-Sung Yoo, Byung Chul Chun. Spatial epidemiologic analysis of the liver cancer and gallbladder cancer incidence and its determinants in South Korea. BMC Public Health 2021; 21(1) doi: 10.1186/s12889-021-12184-8
379
Cuiju Wang, Fengbin Zhang, Haiyan Fan, Li Peng, Ruixing Zhang, Shufeng Liu, Zhanjun Guo. Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome. Biochemical and Biophysical Research Communications 2011; 406(3): 493 doi: 10.1016/j.bbrc.2011.02.088
380
Sathish Kumar Mungamuri, Kotikalapudi Nagasuryaprasad. Epigenetics and Metabolomics. 2021; : 279 doi: 10.1016/B978-0-323-85652-2.00008-7
381
Michal Bitman, Radim Vrzal, Zdenek Dvorak, Petr Pavek. Valproate activates ERK signaling pathway in primary human hepatocytes. Biomedical Papers 2014; 158(1): 039 doi: 10.5507/bp.2012.038
382
Da‐Ni Zhong, Qiu‐Yue Ning, Ji‐Zhou Wu, Ning Zang, Jian‐Lin Wu, Die‐Fei Hu, Shuang‐Yan Luo, Ai‐Chun Huang, Lan‐Lan Li, Guo‐Jian Li. Comparative proteomic profiles indicating genetic factors may involve in hepatocellular carcinoma familial aggregation. Cancer Science 2012; 103(10): 1833 doi: 10.1111/j.1349-7006.2012.02368.x
383
Minkyung Bae, Young-Ki Park, Ji-Young Lee. Food components with antifibrotic activity and implications in prevention of liver disease. The Journal of Nutritional Biochemistry 2018; 55: 1 doi: 10.1016/j.jnutbio.2017.11.003
384
Hongliang Zang, Yuhui Li, Xue Zhang, Guomin Huang. <p>Circ_0000517 Contributes to Hepatocellular Carcinoma Progression by Upregulating TXNDC5 via Sponging miR-1296-5p</p>. Cancer Management and Research 2020; : 3457 doi: 10.2147/CMAR.S244024
385
Markus Casper, Frank Grünhage, Frank Lammert, Kris Kowdley, Geoffrey McCaughan, Christian Trautwein. Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark?. Hepatology 2011; 53(4): 1390 doi: 10.1002/hep.24241
386
Luca Falzone, Andrea Marconi, Carla Loreto, Sabrina Franco, Demetrios A. Spandidos, Massimo Libra. Occupational exposure to carcinogens: Benzene, pesticides and fibers. Molecular Medicine Reports 2016; 14(5): 4467 doi: 10.3892/mmr.2016.5791
387
Trang VoPham, Kimberly A. Bertrand, Jaime E. Hart, Francine Laden, Maria M. Brooks, Jian-Min Yuan, Evelyn O. Talbott, Darren Ruddell, Chung-Chou H. Chang, Joel L. Weissfeld. Pesticide exposure and liver cancer: a review. Cancer Causes & Control 2017; 28(3): 177 doi: 10.1007/s10552-017-0854-6
388
Luca Quagliata, Manuel Schlageter, Cristina Quintavalle, Luigi Tornillo, Luigi Terracciano. Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA). Microarrays 2014; 3(2): 91 doi: 10.3390/microarrays3020091
389
Jeong-Ju Yoo, Eun-Ae Jung, Sang Gyune Kim. Clinical Application of Liver Stiffness Measurement for Assessing the Risk of Hepatocellular Carcinoma. Journal of Liver Cancer 2019; 19(1): 12 doi: 10.17998/jlc.19.1.12
390
Chia-Jui Yen, Masatoshi Kudo, Ho-Yeong Lim, Chih-Hung Hsu, Arndt Vogel, Giovanni Brandi, Rebecca Cheng, Ioana Simona Nitu, Paolo Abada, Yanzhi Hsu, Andrew X. Zhu, Yoon-Koo Kang. Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies. Liver Cancer 2020; 9(4): 440 doi: 10.1159/000506946
391
Lohith Mysuru Shivanna, Asna Urooj. A Review on Dietary and Non-Dietary Risk Factors Associated with Gastrointestinal Cancer. Journal of Gastrointestinal Cancer 2016; 47(3): 247 doi: 10.1007/s12029-016-9845-1
392
Fernando Gomes Romeiro, Luciana Yumi Odani Sigahi, Matheus Alvarez, Fabio da Silva Yamashiro, Fábio Cardoso de Carvalho, Leonardo Pelafsky, Talles Bazeia Lima, Letícia de Campos Franzoni, José Ricardo de Arruda Miranda, Giovanni Faria Silva. Sorafenib after Arterial Chemoembolization in Child-Pugh A and B Cirrhotic Patients with Intermediate Hepatocellular Carcinoma: A Retrospective Analysis. Journal of Cancer Therapy 2015; 6(03): 286 doi: 10.4236/jct.2015.63031
393
Trang VoPham, Maria M. Brooks, Jian-Min Yuan, Evelyn O. Talbott, Darren Ruddell, Jaime E. Hart, Chung-Chou H. Chang, Joel L. Weissfeld. Pesticide exposure and hepatocellular carcinoma risk: A case-control study using a geographic information system (GIS) to link SEER-Medicare and California pesticide data. Environmental Research 2015; 143: 68 doi: 10.1016/j.envres.2015.09.027
394
Toshihiro Furuta, Eriko Maeda, Hiroyuki Akai, Shouhei Hanaoka, Naoki Yoshioka, Masaaki Akahane, Takeyuki Watadani, Kuni Ohtomo. Hepatic Segments and Vasculature: Projecting CT Anatomy onto Angiograms. RadioGraphics 2009; 29(7): e37 doi: 10.1148/rg.e37
395
M Dai, J Liu, D-E Chen, Y Rao, Z-J Tang, W-Z Ho, C-Y Dong. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice. Cancer Gene Therapy 2012; 19(2): 77 doi: 10.1038/cgt.2011.65
396
Zhaleh Farokhizadeh, Sahar Dehbidi, Bita Geramizadeh, Ramin Yaghobi, Seyed Ali Malekhosseini, Mehrdad Behmanesh, Mohammad Hossein Sanati, Afsoon Afshari, Ali Moravej, Mohammad Hossein Karimi. Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population. Annals of Laboratory Medicine 2019; 39(1): 58 doi: 10.3343/alm.2019.39.1.58
397
Hyeong-Geug Kim, Seong-Soon Jang, Jin-Seok Lee, Hyo-Seon Kim, Chang-Gue Son. Panax ginseng Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis. Journal of Ginseng Research 2017; 41(2): 159 doi: 10.1016/j.jgr.2016.02.006
398
Yasunori Minami, Masatoshi Kudo. Biotargets of Cancer in Current Clinical Practice. 2012; : 273 doi: 10.1007/978-1-61779-615-9_10
399
Nghi B. Ha, Nghiem B. Ha, Aijaz Ahmed, Walid Ayoub, Tami J. Daugherty, Ellen T. Chang, Glen A. Lutchman, Gabriel Garcia, Allen D. Cooper, Emmet B. Keeffe, Mindie H. Nguyen. Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study. Cancer Causes & Control 2012; 23(3): 455 doi: 10.1007/s10552-012-9895-z
400
Mary Qian YY, Rong Yuwei J, Peter Angus, Tony Schelleman, Lynne Johnson, Paul Gow. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. Journal of Gastroenterology and Hepatology 2010; 25(5): 951 doi: 10.1111/j.1440-1746.2009.06203.x
401
Zhan Gu, Xiuzhong Qi, Xiaofeng Zhai, Qingbo Lang, Jianying Lu, Changping Ma, Long Liu, Xiaoqiang Yue. Study on TCM Syndrome Differentiation of Primary Liver Cancer Based on the Analysis of Latent Structural Model. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/761565
402
Arun J. Sanyal, Seung Kew Yoon, Riccardo Lencioni. The Etiology of Hepatocellular Carcinoma and Consequences for Treatment. The Oncologist 2010; 15(S4): 14 doi: 10.1634/theoncologist.2010-S4-14
403
Luciana Kikuchi, Aline L Chagas, Regiane SSM Alencar, Denise C Paranaguá-Vezozzo, Flair J Carrilho. Clinical and Epidemiological Aspects of Hepatocellular Carcinoma in Brazil. Antiviral Therapy 2013; 18(3_part_2): 445 doi: 10.3851/IMP2602
404
Yun Hee Kang, Mi-Young Park, Do-Young Yoon, Seung Ro Han, Chung Il Lee, Na Young Ji, Pyung-Keun Myung, Hee Gu Lee, Jae Wha Kim, Young Il Yeom, Ye Jin Jang, Dong Kuk Ahn, Jong Wan Kim, Eun Young Song. Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2. Cancer Letters 2012; 318(2): 226 doi: 10.1016/j.canlet.2011.12.023
405
Hiroyuki Akai, Izuru Matsuda, Shigeru Kiryu, Taku Tajima, Hidemasa Takao, Yasushi Watanabe, Hiroshi Imamura, Norihiro Kokudo, Masaaki Akahane, Kuni Ohtomo. Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging. European Journal of Radiology 2012; 81(11): 2973 doi: 10.1016/j.ejrad.2012.01.007
406
Areum Sohn, Hyunsoo Kim, Su Jong Yu, Jung-Hwan Yoon, Youngsoo Kim. A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma. Analytical and Bioanalytical Chemistry 2017; 409(11): 2829 doi: 10.1007/s00216-017-0227-8
407
Omar Massoud, Michael Charlton. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clinics in Liver Disease 2018; 22(1): 201 doi: 10.1016/j.cld.2017.08.014
408
Sene Waly Raphael, Zhang Yangde, Chen YuXiang. Hepatocellular Carcinoma: Focus on Different Aspects of Management. ISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/421673
409
Hans-Christian Pommergaard, Andreas Arendtsen Rostved, René Adam, Mauro Salizzoni, Miguel Angel Gómez Bravo, Daniel Cherqui, Paolo De Simone, Pauline Houssel-Debry, Vincenzo Mazzaferro, Olivier Soubrane, Juan Carlos García-Valdecasas, Joan Fabregat Prous, Antonio D. Pinna, John O’Grady, Vincent Karam, Christophe Duvoux, Lau Caspar Thygesen. Mortality after Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry. Liver Cancer 2020; 9(4): 455 doi: 10.1159/000507397
410
Marcela Salomao, Helen Remotti, Roger Vaughan, Abby B. Siegel, Jay H. Lefkowitch, Roger Klein Moreira. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Human Pathology 2012; 43(5): 737 doi: 10.1016/j.humpath.2011.07.005
411
Adeyinka C. Adejumo, Tokunbo O. Ajayi, Oluwole M. Adegbala, Kelechi L. Adejumo, Samson Alliu, Akintunde M. Akinjero, Nnaemeka E. Onyeakusi, Ogooluwa Ojelabi, Terence N. Bukong. Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease. Liver International 2018; 38(8): 1475 doi: 10.1111/liv.13696
412
Yi‐Chuan Yu, Pedram Paragomi, Renwei Wang, Feiran Liang, Hung N. Luu, Jaideep Behari, Jian‐Min Yuan. High serum magnesium is associated with lower risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease. Cancer 2023; 129(15): 2341 doi: 10.1002/cncr.34799
413
Olusegun Sylvester Ojo. Liver cancer in Africa: untold aspects of an acknowledged scourge. The Lancet Gastroenterology & Hepatology 2017; 2(2): 76 doi: 10.1016/S2468-1253(16)30179-0
414
Luca Quagliata, Mariacarla Andreozzi, Michal Kovac, Luigi Tornillo, Zuzanna Makowska, Francesca Moretti, Markus H. Heim, Karl Heinimann, Salvatore Piscuoglio, Luigi Maria Terracciano. SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules. European Journal of Cancer 2014; 50(4): 731 doi: 10.1016/j.ejca.2013.11.018
415
Derya Korkmaz, Petek Konya, Neşe Demirtürk. Investigation of the Characteristics of Crimean Congo Hemorrhagic Fever Cases Reported in Afyonkarahisar Province. Turkish Journal of Parasitology 2022; 46(3): 224 doi: 10.4274/tpd.galenos.2022.14633
416
Kenji Imai, Koji Takai, Yoichi Nishigaki, Shogo Shimizu, Takafumi Naiki, Hideki Hayashi, Takahiro Uematsu, Junichi Sugihara, Eiichi Tomita, Masahito Shimizu, Masahito Nagaki, Hisataka Moriwaki. Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus‐positive patients: A prospective, case series study. Hepatology Research 2010; 40(4): 376 doi: 10.1111/j.1872-034X.2009.00616.x
417
Fei Gao, Huifang Liang, Hanlin Lu, Junwen Wang, Meng Xia, Zhimei Yuan, Yu Yao, Tong Wang, Xiaolong Tan, Arian Laurence, Hua Xu, Jingjing Yu, Wei Xiao, Wei Chen, Ming Zhou, Xiuqing Zhang, Qian Chen, Xiaoping Chen. Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approach. Clinical Epigenetics 2015; 7(1) doi: 10.1186/s13148-015-0121-1
418
Hua Zhang, Yumei Cao, Yuru Chen, Guangxi Li, Hanshu Yu. Apatinib promotes apoptosis of the SMMC-7721 hepatocellular carcinoma cell line via the PI3K/Akt pathway. Oncology Letters 2018;  doi: 10.3892/ol.2018.8031
419
Lawrence Wing Chi Chan, Sze Chuen Cesar Wong, William Chi Shing Cho, Mohan Huang, Fei Zhang, Man Lik Chui, Una Ngo Yin Lai, Tiffany Yuen Kwan Chan, Zoe Hoi Ching Cheung, Jerry Chun Yin Cheung, Kin Fu Tang, Man Long Tse, Hung Kit Wong, Hugo Man Fung Kwok, Xinping Shen, Sailong Zhang, Keith Wan Hang Chiu. Primary Tumor Radiomic Model for Identifying Extrahepatic Metastasis of Hepatocellular Carcinoma Based on Contrast Enhanced Computed Tomography. Diagnostics 2022; 13(1): 102 doi: 10.3390/diagnostics13010102
420
ZHIKUN LIU, QI LING, JIANGUO WANG, HAIYANG XIE, XIAO XU, SHUSEN ZHENG. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis. Oncology Letters 2013; 6(1): 125 doi: 10.3892/ol.2013.1337
421
Antonio Giorgio, Antonella Di Sarno, Giorgio de Stefano, Nunzia Farella, Umberto Scognamiglio, Manuela de Stefano, Valentina Giorgio. Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus?. American Journal of Roentgenology 2009; 193(4): 948 doi: 10.2214/AJR.08.2087
422
Stephanie Channual, Anokh Pahwa, David S. Lu, Steven S. Raman. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging. Abdominal Radiology 2016; 41(9): 1825 doi: 10.1007/s00261-016-0767-y
423
Yang Li, Yihong Cai, He Chen, Leijin Mao. Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 2): S486 doi: 10.4103/0973-1482.181179
424
Shantel Olivares, Richard M. Green, Anne S. Henkel, Rajesh Mohanraj. Endoplasmic Reticulum Stress Activates the Hepatic Activator Protein 1 Complex via Mitogen Activated Protein Kinase-Dependent Signaling Pathways. PLoS ONE 2014; 9(7): e103828 doi: 10.1371/journal.pone.0103828
425
Marco Di Pietropaolo, Chiara Briani, Giulia Francesca Federici, Massimo Marignani, Paola Begini, Gianfranco Delle Fave, Elsa Iannicelli. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules. Clinical Imaging 2015; 39(3): 468 doi: 10.1016/j.clinimag.2014.12.020
426
Magdalena Stepien, Talita Duarte‐Salles, Veronika Fedirko, Anne Floegel, Dinesh Kumar Barupal, Sabina Rinaldi, David Achaintre, Nada Assi, Anne Tjønneland, Kim Overvad, Nadia Bastide, Marie‐Christine Boutron‐Ruault, Gianluca Severi, Tilman Kühn, Rudolf Kaaks, Krasimira Aleksandrova, Heiner Boeing, Antonia Trichopoulou, Christina Bamia, Pagona Lagiou, Calogero Saieva, Claudia Agnoli, Salvatore Panico, Rosario Tumino, Alessio Naccarati, H. B(as). Bueno‐de‐Mesquita, Petra H. Peeters, Elisabete Weiderpass, J. Ramón Quirós, Antonio Agudo, María‐José Sánchez, Miren Dorronsoro, Diana Gavrila, Aurelio Barricarte, Bodil Ohlsson, Klas Sjöberg, Mårten Werner, Malin Sund, Nick Wareham, Kay‐Tee Khaw, Ruth C. Travis, Julie A. Schmidt, Marc Gunter, Amanda Cross, Paolo Vineis, Isabelle Romieu, Augustin Scalbert, Mazda Jenab. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study. International Journal of Cancer 2016; 138(2): 348 doi: 10.1002/ijc.29718
427
Fang Yuan, Lu-Shun Zhang, Hong-Yu Li, Miao Liao, MeiLi Lv, ChongJie Zhang. Influence of Angiotensin I-Converting Enzyme Gene Polymorphism on Hepatocellular Carcinoma Risk in China. DNA and Cell Biology 2013; 32(5): 268 doi: 10.1089/dna.2012.1910
428
Ran Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut and Liver 2016; 10(3) doi: 10.5009/gnl15257
429
Infectious Causes of Cancer. 2010; : 106 doi: 10.1002/9780470753651.ch7
430
Sudip Sanyal, Philipp Kron, Neil Wylie, Ernest Hildalgo, Giles J. Toogood, Peter Lodge. Outcomes of liver resection for hepatocellular carcinoma in octogenarians. HPB 2020; 22(9): 1324 doi: 10.1016/j.hpb.2020.01.006
431
Shaimaa Gamal Hassan Elofey, Nevine F. Shafik, Noha Hassan Radwan, Osman Mohammed Mansour, Rasha Mahmoud Allam, Samia Shouman, Iman Attia AbdelGawad. Relation between GSTP1 polymorphism and oxidative stress in patients with hepatocellular carcinoma. Journal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-00049-x
432
Lisha Mou, Kang Li, Chenyang Xu, Irene Xu, Yiyuan Yang, Zuhui Pu. Construction of endothelial cell‐related and autophagy‐related prognostic models for hepatocellular carcinoma based on single‐cell data. Journal of Gastroenterology and Hepatology 2023; 38(5): 809 doi: 10.1111/jgh.16172
433
Liang Shi, Yili Feng, Hui Lin, Rui Ma, Xiujun Cai. Role of estrogen in hepatocellular carcinoma: is inflammation the key?. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/1479-5876-12-93
434
Nastaran Hajizadeh, Ahmad Reza Baghestani, Mohamad Amin Pourhoseingholi, Sara Ashtari, Zeinab Fazeli, Mohsen Vahedi, Mohammad Reza Zali. Trend of hepatocellular carcinoma incidence after Bayesian correction for misclassified data in Iranian provinces. World Journal of Hepatology 2017; 9(15): 704-710 doi: 10.4254/wjh.v9.i15.704
435
Laura Ladrón de Guevara,, Paulo Rojas-Macuil, Xochiquetzal Sánchez-Chávez, Alejandro Rossano-García,, Ma. Teresa Gorraez-de-la-Mora,, Guadalupe Cervantes-Sánchez,, Julita Orozco-Vázquez, Mario Lemus-Velázquez,, Leticia Rosas-Zúñiga,, Aura Erazo-Valle,, Mauricio Di-Silvio. Hepatocellular carcinoma: Epidemiological profile from a cohort of federal employees in Mexico. Annals of Hepatology 2009; 8(3): 212 doi: 10.1016/S1665-2681(19)31768-5
436
Junfa Yang, Changyao Li, Lei Zhang, Xiao Wang. Extracellular Vesicles as Carriers of Non-coding RNAs in Liver Diseases. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00415
437
Xin you Su, Jian Qiang Zhao, Nan Li, Mukesh Kumar, Ai mei Ou yang. Chemoprotective Effects of Resveratrol Against Diethylnitrosamine Induced Hepatocellular Carcinoma in Wistar Rats. International Journal of Pharmacology 2019; 15(5): 549 doi: 10.3923/ijp.2019.549.559
438
Hang Yuan, Jiaxi Mao, Cong Liu, Hong Fu, Wenyuan Guo, Guoshan Ding. Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6): 845 doi: 10.1016/j.clinre.2020.02.012
439
Michele Di Martino, Gianmaria De Filippis, Adriano De Santis, Daniel Geiger, Maurizio Del Monte, Concetta Valentina Lombardo, Massimo Rossi, Stefano Ginanni Corradini, Gianluca Mennini, Carlo Catalano. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging. European Radiology 2013; 23(4): 887 doi: 10.1007/s00330-012-2691-z
440
Jui-Hsiang Lin, An-Shun Tai, Sheng-Hsuan Lin. Population attributable fraction based on marginal sufficient component cause model for mediation settings. Annals of Epidemiology 2022; 75: 57 doi: 10.1016/j.annepidem.2022.08.050
441
Yen-Ju Chen, Chih-Jung Shen, Shao-Hua Yu, Cheng-Li Lin, Hong-Mo Shih. Increased risk of hepatocellular carcinoma in patients with traumatic liver injury. Medicine 2022; 101(6): e28837 doi: 10.1097/MD.0000000000028837
442
Ahmed Tayel, Khaled H. Abd El Galil, Mohamed A. Ebrahim, Ahmed S. Ibrahim, Amal M. El-Gayar, Mohammed M.H. Al-Gayyar. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme. European Journal of Pharmacology 2014; 728: 151 doi: 10.1016/j.ejphar.2014.02.001
443
Hans‐Christian Pommergaard. Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma. APMIS 2023; 131(S146): 1 doi: 10.1111/apm.13309
444
Silvia Gangemi, Eliza Gofita, Chiara Costa, Michele Teodoro, Giusi Briguglio, Dragana Nikitovic, George Tzanakakis, Aristides M. Tsatsakis, Martin F. Wilks, Demetrios A. Spandidos, Concettina Fenga. Occupational and environmental exposure to pesticides and cytokine pathways in chronic diseases (Review). International Journal of Molecular Medicine 2016; 38(4): 1012 doi: 10.3892/ijmm.2016.2728
445
Jeong Min Lee, Dong Ho Lee, Jeong-Hee Yoon. Multislice-CT of the Abdomen. Medical Radiology 2012; : 47 doi: 10.1007/174_2012_538
446
CHENG-LIANG ZHU, DUO-ZHI CHENG, FANG LIU, XIAO-HONG YAN, KAI-LANG WU, FU-BING WANG, XING-HUI LIU. Hepatitis B virus upregulates the expression of kinesin family member 4A. Molecular Medicine Reports 2015; 12(3): 3503 doi: 10.3892/mmr.2015.3792
447
Shaobo Zhang, Jian Qian, Qiang Cao, Pu Li, Meilin Wang, Jian Wang, Xiaobing Ju, Xiaoxin Meng, Qiang Lu, Pengfei Shao, Zhengdong Zhang, Chao Qin, Changjun Yin. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population. Mutagenesis 2014; 29(2): 149 doi: 10.1093/mutage/geu001
448
M. A. D. Vente, J. F. W. Nijsen, R. de Roos, M. J. van Steenbergen, C. N. J. Kaaijk, M. J. J. Koster-Ammerlaan, P. F. A. de Leege, W. E. Hennink, A. D. van het Schip, G. C. Krijger. Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radioembolization: a validation study. Biomedical Microdevices 2009; 11(4): 763 doi: 10.1007/s10544-009-9291-y
449
Jin-yan Zhao, Zhi-hong Chen, Wei Lin, Xiao-yong Zhong, Xu-zheng Chen, Jun Peng, Zhen-feng Hong. Bear bile powder (熊胆粉) induces apoptosis of human hepatocellular carcinoma cells via mitochondrion-dependent pathway. Chinese Journal of Integrative Medicine 2014; 20(2): 123 doi: 10.1007/s11655-013-1581-9
450
Teddy Saliba, Stephan Dorkhom, Eileen M. OʼReilly, Emmy Ludwig, Bolorsukh Gansukh, Ghassan K. Abou-Alfa. Hepatocellular carcinoma in two patients with cardiac cirrhosis. European Journal of Gastroenterology & Hepatology 2010; 22(7): 889 doi: 10.1097/MEG.0b013e32832e2bec
451
LI ZHANG, CUIJU WANG, SHUFENG LIU, YUFEI ZHAO, CHAO LIU, ZHANJUN GUO. Prognostic significance of Dicer expression in hepatocellular carcinoma. Oncology Letters 2016; 11(6): 3961 doi: 10.3892/ol.2016.4547
452
Jaitip Tipanee, Mario Di Matteo, Warut Tulalamba, Ermira Samara-Kuko, Jiri Keirsse, Jo A. Van Ginderachter, Marinee Khim Chuah, Thierry VandenDriessche. Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons. Molecular Therapy - Nucleic Acids 2020; 19: 1309 doi: 10.1016/j.omtn.2020.01.015
453
Talita Duarte‐Salles, Veronika Fedirko, Magdalena Stepien, Krasimira Aleksandrova, Christina Bamia, Pagona Lagiou, Anne Sofie Dam Laursen, Louise Hansen, Kim Overvad, Anne Tjønneland, Marie‐Christine Boutron‐Ruault, Guy Fagherazzi, Mathilde His, Heiner Boeing, Verena Katzke, Tilman Kühn, Antonia Trichopoulou, Elissavet Valanou, Maria Kritikou, Giovanna Masala, Salvatore Panico, Sabina Sieri, Fulvio Ricceri, Rosario Tumino, H. B(as) Bueno‐de‐Mesquita, Petra H. Peeters, Anette Hjartåker, Guri Skeie, Elisabete Weiderpass, Eva Ardanaz, Catalina Bonet, Maria‐Dolores Chirlaque, Miren Dorronsoro, J. Ramón Quirós, Ingegerd Johansson, Bodil Ohlsson, Klas Sjöberg, Maria Wennberg, Kay‐Tee Khaw, Ruth C. Travis, Nick Wareham, Pietro Ferrari, Heinz Freisling, Isabelle Romieu, Amanda J. Cross, Marc Gunter, Yunxia Lu, Mazda Jenab. Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort. International Journal of Cancer 2015; 137(11): 2715 doi: 10.1002/ijc.29643
454
Flávia Miryan Martins Almeida de Mello, Aline Satie Oba Kuniyoshi, André Fanhani Lopes, Michele Soares Gomes-Gouvêa, Dennis Armando Bertolini. Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers. Revista da Sociedade Brasileira de Medicina Tropical 2014; 47(6): 701 doi: 10.1590/0037-8682-0158-2014
455
Ina Schönfeld, Klaus Kraywinkel. Epidemiologie des hepatozellulären Karzinoms in Deutschland. Der Onkologe 2018; 24(9): 653 doi: 10.1007/s00761-018-0438-4
456
Pierre-Benoit Ancey, Barbara Testoni, Marion Gruffaz, Marie-Pierre Cros, Geoffroy Durand, Florence Le Calvez-Kelm, David Durantel, Zdenko Herceg, Hector Hernandez-Vargas. Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes. Oncotarget 2015; 6(42): 44877 doi: 10.18632/oncotarget.6270
457
Maria-Aggeliki Kalogeridi, Anna Zygogianni, George Kyrgias, John Kouvaris, Sofia Chatziioannou, Nikolaos Kelekis, Vassilis Kouloulias. Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review. World Journal of Hepatology 2015; 7(1): 101-112 doi: 10.4254/wjh.v7.i1.101
458
Concetta Panebianco, Adele Potenza, Angelo Andriulli, Valerio Pazienza. Exploring the microbiota to better understand gastrointestinal cancers physiology. Clinical Chemistry and Laboratory Medicine (CCLM) 2018; 56(9): 1400 doi: 10.1515/cclm-2017-1163
459
Jiumao Lin, Aling Shen, Hongwei Chen, Jun Liao, Teng Xu, Liya Liu, Jing Lin, Jun Peng. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-729
460
Mark Benedict, Xuchen Zhang. Non-alcoholic fatty liver disease: An expanded review. World Journal of Hepatology 2017; 9(16): 715-732 doi: 10.4254/wjh.v9.i16.715
461
Elaine Holmes, Anisha Wijeyesekera, Simon D. Taylor-Robinson, Jeremy K. Nicholson. The promise of metabolic phenotyping in gastroenterology and hepatology. Nature Reviews Gastroenterology & Hepatology 2015; 12(8): 458 doi: 10.1038/nrgastro.2015.114
462
Ce Chao, Renzhe Tang, Jiamin Zhao, Dongmei Di, Yongxiang Qian, Bin Wang. Oncogenic roles and related mechanisms of the long non-coding RNA MINCR in human cancers. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1087337
463
Michele Molinari, Christof Kaltenmeier, Patrick-Bou Samra, Hao Liu, Charles Wessel, Mary Lou Klem, Stalin Dharmayan, Bishoy Emmanuel, Hasan Al Harakeh, Samer Tohme, David Geller, Amit Tevar, Christopher B. Hughes, Abhinav Humar, Ramon Bataller, Jaideep Behari. Hepatic Resection for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Annals of Surgery Open 2021; 2(2): e065 doi: 10.1097/AS9.0000000000000065
464
Massimiliano Berretta, Michele Caraglia, Ferdinando Martellotta, Silvia Zappavigna, Angela Lombardi, Carla Fierro, Luigi Atripaldi, Tommaso Muto, Daniela Valente, Paolo De Paoli, Umberto Tirelli, Raffaele Di Francia. Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00071
465
Wei Liu, Fang Tian, Liping Dai, Yurong Chai. Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a meta-analysis. Molecular Biology Reports 2014; 41(11): 7645 doi: 10.1007/s11033-014-3655-y
466
Norhanan Hamzah, Nur Karyatee Kassim, Julia Omar, Mohd Shafie Abdullah, Yeong Yeh Lee. Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions. PeerJ 2023; 11: e15988 doi: 10.7717/peerj.15988
467
Nada Assi, Anne Fages, Paolo Vineis, Marc Chadeau-Hyam, Magdalena Stepien, Talita Duarte-Salles, Graham Byrnes, Houda Boumaza, Sven Knüppel, Tilman Kühn, Domenico Palli, Christina Bamia, Hendriek Boshuizen, Catalina Bonet, Kim Overvad, Mattias Johansson, Ruth Travis, Marc J. Gunter, Eiliv Lund, Laure Dossus, Bénédicte Elena-Herrmann, Elio Riboli, Mazda Jenab, Vivian Viallon, Pietro Ferrari. A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study. Mutagenesis 2015; : gev045 doi: 10.1093/mutage/gev045
468
Robin K. Kelley, Alan P. Venook. Sorafenib in Hepatocellular Carcinoma: Separating the Hype From the Hope. Journal of Clinical Oncology 2008; 26(36): 5845 doi: 10.1200/JCO.2008.19.7996
469
Jan Vargas, Mathew Gowans, William A. Vandergrift, Pierre Giglio, Jason Hope. Metastatic Hepatocellular Carcinoma With Associated Spinal Cord Compression. The American Journal of the Medical Sciences 2011; 341(2): 148 doi: 10.1097/MAJ.0b013e3181f7a49a
470
Xu Chao, Xuesong Feng, Hailong Shi, Yuewen Wang, Lanlan Wang, Haiyu Shen, Qing Zha, Yanni Chen, Chao Jiang. MIR17HG polymorphism (rs7318578) is associated with liver cancer risk in the Chinese Han population. Bioscience Reports 2020; 40(8) doi: 10.1042/BSR20193312
471
M Arafa, T Besheer, AM El-Eraky, SM Abo El-khair, AZ Elsamanoudy. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients. British Journal of Biomedical Science 2019; 76(2): 64 doi: 10.1080/09674845.2019.1594487
472
Rajesh Melaram. Environmental Risk Factors Implicated in Liver Disease: A Mini-Review. Frontiers in Public Health 2021; 9 doi: 10.3389/fpubh.2021.683719
473
Ping Wang, Donghong Kang, Wei Cao, Yan Wang, Zhiwen Liu. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis. Diabetes/Metabolism Research and Reviews 2012; 28(2): 109 doi: 10.1002/dmrr.1291
474
Naoki Fujita, Yoshiyuki Takei. . Advances in Clinical Chemistry 2011; 55: 105 doi: 10.1016/B978-0-12-387042-1.00006-X
475
Ya-Wen Cheng, Kai-Wei Chen, Han-Chun Kuo, Ching-Hua Kuo, Wei-Hsiang Lin, Pei-Jer Chen, Shiou-Hwei Yeh. Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes. International Journal of Obesity 2019; 43(12): 2469 doi: 10.1038/s41366-019-0431-z
476
Jui-Kun Chiang, Lin Chih-Wen, Yee-Hsin Kao. Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study. BMJ Open 2017; 7(6): e015936 doi: 10.1136/bmjopen-2017-015936
477
Mrigaya Mehra, Ranjit Chauhan. Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma. Biomarkers in Cancer 2017; 9: 1179299X1773730 doi: 10.1177/1179299X17737301
478
E. Okeke, P. Mark Davwar, B. Mullen, M. Duguru, O. Agbaji, A. Sagay, R. Murphy, C. Hawkins. The impact of HIV on hepatocellular cancer survival in Nigeria. Tropical Medicine & International Health 2021; 26(3): 335 doi: 10.1111/tmi.13532
479
Jelena Jadzic, Danijela Djonic. Hepatocellular carcinoma and musculoskeletal system: A narrative literature review. World Journal of Gastroenterology 2024; 30(15): 2109-2117 doi: 10.3748/wjg.v30.i15.2109
480
Lorenzo Monfardini, Franco Orsi, Silvio Monfardini. Interventional oncology for older patients in liver and kidney malignancies. Aging Health 2012; 8(3): 287 doi: 10.2217/ahe.12.18
481
Magdalena Stepien, Talita Duarte-Salles, Veronika Fedirko, Antonia Trichopoulou, Pagona Lagiou, Christina Bamia, Kim Overvad, Anne Tjønneland, Louise Hansen, Marie-Christine Boutron-Ruault, Guy Fagherazzi, Gianluca Severi, Tilman Kühn, Rudolf Kaaks, Krasimira Aleksandrova, Heiner Boeing, Eleni Klinaki, Domenico Palli, Sara Grioni, Salvatore Panico, Rosario Tumino, Alessio Naccarati, H. Bas Bueno-de-Mesquita, Petra H. Peeters, Guri Skeie, Elisabete Weiderpass, Christine L. Parr, José Ramón Quirós, Genevieve Buckland, Esther Molina-Montes, Pilar Amiano, Maria-Dolores Chirlaque, Eva Ardanaz, Emily Sonestedt, Ulrika Ericson, Maria Wennberg, Lena Maria Nilsson, Kay-Tee Khaw, Nick Wareham, Kathryn E. Bradbury, Heather A. Ward, Isabelle Romieu, Mazda Jenab. Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort. European Journal of Nutrition 2016; 55(1): 7 doi: 10.1007/s00394-014-0818-5
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345